## SETH LERNER

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Urology  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Jac182vCMqv3RYKj5X%2fX&rnd=61eb0ae3-a23d-41aa-8d5d-6027c62cedce)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=267959)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=267959&cachekey=8b07ae85-d3a3-49be-8adf-e9e17b8fc198)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Gebrael G, Jo Y, Swami U, Plets M, Hage Chehade C, Narang A, Gupta S, Myint ZW, Sayegh N, Tangen CM, Hussain M, Dorff T, Lara PN, **Lerner SP** , Thompson I, Agarwal N. Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial. JAMA Netw Open. 2024 Jul 01; 7(7):e2419966. PMID: [38980676](//www.ncbi.nlm.nih.gov/pubmed/38980676); PMCID: [PMC11234233](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11234233).

Citations:  Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  2. Jin F, Thaiparambil J, Donepudi SR, Vantaku V, Piyarathna DWB, Maity S, Krishnapuram R, Putluri V, Gu F, Purwaha P, Bhowmik SK, Ambati CR, von Rundstedt FC, Roghmann F, Berg S, Noldus J, Rajapakshe K, G?dde D, Roth S, St?rkel S, Degener S, Michailidis G, [Kaipparettu BA](https://profiles.viictr.org/profile/269257), Karanam B, Terris MK, Kavuri SM, **Lerner SP** , [Kheradmand F](https://profiles.viictr.org/profile/270223), [Coarfa C](https://profiles.viictr.org/profile/265668), [Sreekumar A](https://profiles.viictr.org/profile/266636), Lotan Y, El-Zein R, [Putluri N](https://profiles.viictr.org/profile/269361). Retraction: Tobacco-specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer. Cancer Prev Res (Phila). 2024 Jun 04; 17(6):281. PMID: [38831722](//www.ncbi.nlm.nih.gov/pubmed/38831722).

Citations:  Fields:

Neo Neoplasms

  3. Lara PN, Tangen C, Heath EI, Gulati S, Stein MN, Meng M, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo R, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, **Lerner S** , Thompson IM, Ryan CW. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. Eur Urol. 2024 May 28. PMID: [38811313](//www.ncbi.nlm.nih.gov/pubmed/38811313).

Citations:  Fields:

Uro Urology

  4. Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, [Kamat AM](https://profiles.viictr.org/profile/12582620), Bivalacqua TJ, Montgomery JS, **Lerner SP** , Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, [Dinney CPN](https://profiles.viictr.org/profile/12583684). Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86. PMID: [38704840](//www.ncbi.nlm.nih.gov/pubmed/38704840).

Citations:  Fields:

Uro Urology

Translation:HumansCellsCTClinical Trials

  5. Pal SK, Grivas P, Gupta S, Dizman N, Zengin Z, Valderrama BP, Rodriguez-Vida A, Roghmann F, Sevillano Fernandez E, [Matin SF](https://profiles.viictr.org/profile/12583401), Loriot Y, Sridhar SS, Sonpavde G, Fleming MT, **Lerner SP** , Bellmunt J, Master V, Tripathi A, Davis K, van Veenhuyzen D, Weng R, Daneshmand S. Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial. Eur Urol. 2024 Apr 04. PMID: [38580518](//www.ncbi.nlm.nih.gov/pubmed/38580518).

Citations:  Fields:

Uro Urology

  6. Parikh M, Tangen C, Hussain MHA, Gupta S, Callis S, Jo Y, Harzstark A, Paller CJ, George S, Zibelman MR, Cheng HH, Maughan BL, Zhang J, Pachynski RK, Bryce AH, Lin DW, Quinn DI, **Lerner SP** , Thompson IM, Dorff TB, Lara PN, Agarwal N. Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide. Eur Urol Oncol. 2024 Mar 23. PMID: [38523017](//www.ncbi.nlm.nih.gov/pubmed/38523017).

Citations:  Fields:

Neo NeoplasmsUro Urology

  7. McConkey DJ, Baumann BC, Cooper Greenberg S, DeGraff DJ, Delacroix SE, Efstathiou JA, Foster J, Groshen S, Kadel EE, Khani F, Kim WY, **Lerner SP** , Levin T, Liao JC, Milowsky MI, Meeks JJ, Miyamoto DT, Mouw KW, Pietzak EJ, Solit DB, Sundi D, Tawab-Amiri A, West PJ, Wobker SE, Wyatt AW, Apolo AB, Black PC. Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer. Bladder Cancer. 2024; 10(1):1-8. PMID: [38993535](//www.ncbi.nlm.nih.gov/pubmed/38993535); PMCID: [PMC11181871](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11181871).

Citations:

  8. Amara CS, [Kami Reddy KR](https://profiles.viictr.org/profile/28999415), Yuntao Y, Chan YS, Piyarathna DWB, Dobrolecki LE, Shih DJH, Shi Z, Xu J, Huang S, Ellis MJ, Apolo AB, Ballester LY, [Gao J](https://profiles.viictr.org/profile/12582803), Hansel DE, Lotan Y, Hodges HC, **Lerner SP** , [Creighton CJ](https://profiles.viictr.org/profile/265729), [Sreekumar A](https://profiles.viictr.org/profile/266636), Zheng WJ, Msaouel P, Kavuri SM, [Putluri N](https://profiles.viictr.org/profile/269361). The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nat Commun. 2024 Feb 14; 15(1):1373. PMID: [38355560](//www.ncbi.nlm.nih.gov/pubmed/38355560); PMCID: [PMC10867091](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10867091).

Citations:  Fields:

Bio BiologySci Science

Translation:HumansCells

  9. Abu-Shawareb H, Acree R, Adams P, Adams J, Addis B, Aden R, Adrian P, Afeyan BB, Aggleton M, Aghaian L, Aguirre A, Aikens D, Akre J, Albert F, Albrecht M, Albright BJ, Albritton J, Alcala J, Alday C, Alessi DA, Alexander N, Alfonso J, Alfonso N, Alger E, Ali SJ, Ali ZA, Allen A, Alley WE, Amala P, Amendt PA, Amick P, Ammula S, Amorin C, Ampleford DJ, Anderson RW, Anklam T, Antipa N, Appelbe B, Aracne-Ruddle C, Araya E, Archuleta TN, Arend M, Arnold P, Arnold T, Arsenlis A, Asay J, Atherton LJ, Atkinson D, Atkinson R, Auerbach JM, Austin B, Auyang L, Awwal AAS, Aybar N, Ayers J, Ayers S, Ayers T, Azevedo S, Bachmann B, Back CA, Bae J, Bailey DS, Bailey J, Baisden T, Baker KL, Baldis H, Barber D, Barberis M, Barker D, Barnes A, Barnes CW, Barrios MA, Barty C, Bass I, Batha SH, Baxamusa SH, Bazan G, Beagle JK, Beale R, Beck BR, Beck JB, Bedzyk M, Beeler RG, Behrendt W, Belk L, Bell P, Belyaev M, Benage JF, Bennett G, Benedetti LR, Benedict LX, Berger RL, Bernat T, Bernstein LA, Berry B, Bertolini L, Besenbruch G, Betcher J, Bettenhausen R, Betti R, Bezzerides B, Bhandarkar SD, Bickel R, Biener J, Biesiada T, Bigelow K, Bigelow-Granillo J, Bigman V, Bionta RM, Birge NW, Bitter M, Black AC, Bleile R, Bleuel DL, Bliss E, Blue B, Boehly T, Boehm K, Boley CD, Bonanno R, Bond EJ, Bond T, Bonino MJ, Borden M, Bourgade JL, Bousquet J, Bowers J, Bowers M, Boyd R, Boyle D, Bozek A, Bradley DK, Bradley KS, Bradley PA, Bradley L, Brannon L, Brantley PS, Braun D, Braun T, Brienza-Larsen K, Briggs R, Briggs TM, Britten J, Brooks ED, Browning D, Bruhn MW, Brunner TA, Bruns H, Brunton G, Bryant B, Buczek T, Bude J, Buitano L, Burkhart S, Burmark J, Burnham A, Burr R, Busby LE, Butlin B, Cabeltis R, Cable M, Cabot WH, Cagadas B, Caggiano J, Cahayag R, Caldwell SE, Calkins S, Callahan DA, Calleja-Aguirre J, Camara L, Camp D, Campbell EM, Campbell JH, Carey B, Carey R, Carlisle K, Carlson L, Carman L, Carmichael J, Carpenter A, Carr C, Carrera JA, Casavant D, Casey A, Casey DT, Castillo A, Castillo E, Castor JI, Castro C, Caughey W, Cavitt R, Celeste J, Celliers PM, Cerjan C, Chandler G, Chang B, Chang C, Chang J, Chang L, Chapman R, Chapman TD, Chase L, Chen H, Chen H, Chen K, Chen LY, Cheng B, Chittenden J, Choate C, Chou J, Chrien RE, Chrisp M, Christensen K, Christensen M, Christiansen NS, Christopherson AR, Chung M, Church JA, Clark A, Clark DS, Clark K, Clark R, Claus L, Cline B, Cline JA, Cobble JA, Cochrane K, Cohen B, Cohen S, Collette MR, Collins GW, Collins LA, Collins TJB, Conder A, Conrad B, Conyers M, Cook AW, Cook D, Cook R, Cooley JC, Cooper G, Cope T, Copeland SR, Coppari F, Cortez J, Cox J, Crandall DH, Crane J, Craxton RS, Cray M, Crilly A, Crippen JW, Cross D, Cuneo M, Cuotts G, Czajka CE, Czechowicz D, Daly T, Danforth P, Danly C, Darbee R, Darlington B, Datte P, Dauffy L, Davalos G, Davidovits S, Davis P, Davis J, Dawson S, Day RD, Day TH, Dayton M, Deck C, Decker C, Deeney C, DeFriend KA, Deis G, Delamater ND, Delettrez JA, Demaret R, Demos S, Dempsey SM, Desjardin R, Desjardins T, Desjarlais MP, Dewald EL, DeYoreo J, Diaz S, Dimonte G, Dittrich TR, Divol L, Dixit SN, Dixon J, Do A, Dodd ES, Dolan D, Donovan A, Donovan M, D?ppner T, Dorrer C, Dorsano N, Douglas MR, Dow D, Downie J, Downing E, Dozieres M, Draggoo V, Drake D, Drake RP, Drake T, Dreifuerst G, Drury O, DuBois DF, DuBois PF, Dunham G, Durocher M, Dylla-Spears R, Dymoke-Bradshaw AKL, Dzenitis B, Ebbers C, Eckart M, Eddinger S, Eder D, Edgell D, Edwards MJ, Efthimion P, Eggert JH, Ehrlich B, Ehrmann P, Elhadj S, Ellerbee C, Elliott NS, Ellison CL, Elsner F, Emerich M, Engelhorn K, England T, English E, Epperson P, Epstein R, Erbert G, Erickson MA, Erskine DJ, Erlandson A, Espinosa RJ, Estes C, Estabrook KG, Evans S, Fabyan A, Fair J, Fallejo R, Farmer N, Farmer WA, Farrell M, Fatherley VE, Fedorov M, Feigenbaum E, Fehrenbach T, Feit M, Felker B, Ferguson W, Fernandez JC, Fernandez-Panella A, Fess S, Field JE, Filip CV, Fincke JR, Finn T, Finnegan SM, et al. Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment. Phys Rev Lett. 2024 Feb 09; 132(6):065102. PMID: [38394591](//www.ncbi.nlm.nih.gov/pubmed/38394591).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38394591/citedby/) Fields:

Med Medicine (General)

  10. [Anurag M](https://profiles.viictr.org/profile/15619466), Strandgaard T, Kim SH, Dou Y, Comperat E, Al-Ahmadie H, Inman BA, Taber A, Nordentoft I, Jensen JB, Dyrskj?t L, **Lerner SP**. Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. iScience. 2024 Mar 15; 27(3):109179. PMID: [38439961](//www.ncbi.nlm.nih.gov/pubmed/38439961); PMCID: [PMC10910238](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10910238).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38439961/citedby/)

  11. **Lerner SP** , McConkey DJ, Tangen CM, Meeks JJ, Flaig TW, Hua X, Daneshmand S, Alva AS, Lucia MS, Theodorescu D, Goldkorn A, Milowsky MI, [Choi W](https://profiles.viictr.org/profile/12583772), Bangs R, Gustafson DL, Plets M, Thompson IM. Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Clin Cancer Res. 2024 01 17; 30(2):444-449. PMID: [37966367](//www.ncbi.nlm.nih.gov/pubmed/37966367); PMCID: [PMC10824507](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10824507).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  12. Myers AA, Briganti A, Leibovich B, **Lerner SP** , Moschini M, Roupr?t M, Shariat SF, Spiess PE, Stenzl A, Taneja SS, Touijer KA, [Kamat AM](https://profiles.viictr.org/profile/12582620). Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? Eur Urol Oncol. 2024 Jun; 7(3):412-420. PMID: [37980250](//www.ncbi.nlm.nih.gov/pubmed/37980250).

Citations:  Fields:

Neo NeoplasmsUro Urology

  13. [Kamat AM](https://profiles.viictr.org/profile/12582620), Apolo AB, Babjuk M, Bivalacqua TJ, Black PC, Buckley R, Campbell MT, Comp?rat E, Efstathiou JA, Grivas P, Gupta S, Kurtz NJ, Lamm D, **Lerner SP** , Li R, McConkey DJ, Palou Redorta J, Powles T, Psutka SP, Shore N, Steinberg GD, Sylvester R, Witjes JA, Galsky MD. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. J Clin Oncol. 2023 Dec 10; 41(35):5437-5447. PMID: [37793077](//www.ncbi.nlm.nih.gov/pubmed/37793077); PMCID: [PMC10713193](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10713193).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37793077/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  14. [DiNardo AR](https://profiles.viictr.org/profile/1826499), Arditi M, [Kamat AM](https://profiles.viictr.org/profile/12582620), Koster KJ, Carrero S, [Nishiguchi T](https://profiles.viictr.org/profile/31729275), Lebedev M, Benjamin AB, Avalos P, Lozano M, Moule MG, McCune B, Herron B, Ladki M, Sheikh D, Spears M, Herrejon IA, Dodge C, Kumar S, Hutchison RW, Ofili TU, Opperman LA, Bernard JA, **Lerner SP** , Udeani G, Neal G, Netea MG, Cirillo JD. Bacillus Calmette-Gu?rin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses. Trials. 2023 Oct 04; 24(1):636. PMID: [37794431](//www.ncbi.nlm.nih.gov/pubmed/37794431); PMCID: [PMC10548680](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10548680).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37794431/citedby/) Fields:

Med Medicine (General)The Therapeutics

Translation:HumansCellsPHPublic Health

  15. Chang E, Hahn NM, **Lerner SP** , Fallah J, Agrawal S, [Kamat AM](https://profiles.viictr.org/profile/12582620), Bhatnagar V, Svatek RS, Jaigirdar AA, Bross P, Shore N, Kates M, Sachse K, Brewer JR, O'Donnell MA, Steinberg GD, Viviano CJ, Bloomquist E, Ribal MJ, Galsky MD, Oliver R, Black PC, Al-Ahmadie H, Brothers K, Pohar K, [Dinney CP](https://profiles.viictr.org/profile/12583684), Feng Z, Downs TM, Porten SP, Smith AB, Bangs R, Psutka SP, Agarwal N, Amiri-Kordestani L, Suzman DL, Pazdur R, Kluetz PG, Weinstock C. Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2023; 9(3):271-286. PMID: [38993184](//www.ncbi.nlm.nih.gov/pubmed/38993184); PMCID: [PMC11181701](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11181701).

Citations:

  16. Black PC, Tangen CM, Singh P, McConkey DJ, Lucia MS, Lowrance WT, Koshkin VS, Stratton KL, Bivalacqua TJ, Kassouf W, Porten SP, Bangs R, Plets M, Thompson IM, **Lerner SP**. Phase 2 Trial of Atezolizumab in Bacillus Calmette-Gu?rin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605. Eur Urol. 2023 12; 84(6):536-544. PMID: [37596191](//www.ncbi.nlm.nih.gov/pubmed/37596191); PMCID: [PMC10869634](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10869634).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37596191/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  17. Tripathi A, **Lerner SP**. Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial Carcinoma. JCO Precis Oncol. 2023 08; 7:e2300293. PMID: [37535882](//www.ncbi.nlm.nih.gov/pubmed/37535882).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37535882/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  18. Flaig TW, Tangen CM, Daneshmand S, Alva AS, Lucia MS, McConkey DJ, Theodorescu D, Goldkorn A, Milowsky MI, Bangs R, MacVicar GR, Bastos BR, Fowles JS, Gustafson DL, Plets M, Thompson IM, **Lerner SP**. Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695). Eur Urol. 2023 09; 84(3):341-347. PMID: [37414705](//www.ncbi.nlm.nih.gov/pubmed/37414705); PMCID: [PMC10659139](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10659139).

Citations:  Fields:

Uro Urology

Translation:HumansCTClinical Trials

  19. Rose KM, Huelster HL, Meeks JJ, Faltas BM, Sonpavde GP, **Lerner SP** , Ross JS, Spiess PE, Grass GD, Jain RK, [Kamat AM](https://profiles.viictr.org/profile/12582620), Vosoughi A, Wang L, Wang X, Li R. Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. Nat Rev Urol. 2023 Jul; 20(7):452. PMID: [37217696](//www.ncbi.nlm.nih.gov/pubmed/37217696).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37217696/citedby/) Fields:

Uro Urology

  20. Jubber I, Ong S, Bukavina L, Black PC, Comp?rat E, [Kamat AM](https://profiles.viictr.org/profile/12582620), Kiemeney L, Lawrentschuk N, **Lerner SP** , Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur Urol. 2023 08; 84(2):176-190. PMID: [37198015](//www.ncbi.nlm.nih.gov/pubmed/37198015).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37198015/citedby/) Fields:

Uro Urology

Translation:HumansPHPublic Health

  21. Lu YT, Plets M, Morrison G, Cunha AT, Cen SY, Rhie SK, Siegmund KD, Daneshmand S, Quinn DI, Meeks JJ, **Lerner SP** , Petrylak DP, McConkey D, Flaig TW, Thompson IM, Goldkorn A. Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314. Eur Urol Oncol. 2023 10; 6(5):516-524. PMID: [37087309](//www.ncbi.nlm.nih.gov/pubmed/37087309); PMCID: [PMC10587361](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10587361).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37087309/citedby/) Fields:

Neo NeoplasmsUro Urology

  22. Patel SR, **Lerner SP**. Evolving the surgical approach for bladder cancer - robotic versus open radical cystectomy. Nat Rev Urol. 2023 04; 20(4):203-204. PMID: [36522471](//www.ncbi.nlm.nih.gov/pubmed/36522471).

Citations:  Fields:

Uro Urology

Translation:Humans

  23. Mehr JP, Bates JN, **Lerner SP**. Is There A Benefit of Restaging Transurethral Resection of Bladder Tumor Prior to Radical Cystectomy With or Without Neoadjuvant Chemotherapy? Bladder Cancer. 2023; 9(1):41-48. PMID: [38994480](//www.ncbi.nlm.nih.gov/pubmed/38994480); PMCID: [PMC11181791](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11181791).

Citations:

  24. Rose KM, Huelster HL, Meeks JJ, Faltas BM, Sonpavde GP, **Lerner SP** , Ross JS, Spiess PE, Grass GD, Jain RK, [Kamat AM](https://profiles.viictr.org/profile/12582620), Vosoughi A, Wang L, Wang X, Li R. Circulating and urinary tumour DNA in urothelial carcinoma?- upper tract, lower tract and metastatic disease. Nat Rev Urol. 2023 07; 20(7):406-419. PMID: [36977797](//www.ncbi.nlm.nih.gov/pubmed/36977797).

Citations:  Fields:

Uro Urology

Translation:Humans

  25. Antonelli L, Sebro K, Lahmar A, Black PC, Ghodoussipour S, Hamilton-Reeves JM, Shah J, Bente Thoft J, **Lerner SP** , Llorente C, Lucca I, Preston MA, Psutka SP, Sfakianos JP, Vahr Lauridsen S, Williams SB, Catto J, Djaladat H, Kassouf W, Loftus K, Daneshmand S, Fankhauser CD, Enhanced Recovery After Surgery ERAS Cystectomy Committee. Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review. Eur Urol Focus. 2023 07; 9(4):631-636. PMID: [36710211](//www.ncbi.nlm.nih.gov/pubmed/36710211).

Citations:  Fields:

Uro Urology

Translation:Humans

  26. [Villanueva H](https://profiles.viictr.org/profile/1826409), Wells GA, Miller MT, Villanueva M, Pathak R, [Castro P](https://profiles.viictr.org/profile/268709), [Ittmann MM](https://profiles.viictr.org/profile/269566), Sikora AG, **Lerner SP**. Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model. Heliyon. 2022 Dec; 8(12):e12570. PMID: [36643309](//www.ncbi.nlm.nih.gov/pubmed/36643309); PMCID: [PMC9834740](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9834740).

Citations:

  27. Kim SH, **Lerner SP**. Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors. J Clin Oncol. 2023 01 10; 41(2):163-166. PMID: [36450101](//www.ncbi.nlm.nih.gov/pubmed/36450101).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  28. Abu-Shawareb H, Acree R, Adams P, Adams J, Addis B, Aden R, Adrian P, Afeyan BB, Aggleton M, Aghaian L, Aguirre A, Aikens D, Akre J, Albert F, Albrecht M, Albright BJ, Albritton J, Alcala J, Alday C, Alessi DA, Alexander N, Alfonso J, Alfonso N, Alger E, Ali SJ, Ali ZA, Alley WE, Amala P, Amendt PA, Amick P, Ammula S, Amorin C, Ampleford DJ, Anderson RW, Anklam T, Antipa N, Appelbe B, Aracne-Ruddle C, Araya E, Arend M, Arnold P, Arnold T, Asay J, Atherton LJ, Atkinson D, Atkinson R, Auerbach JM, Austin B, Auyang L, Awwal AS, Ayers J, Ayers S, Ayers T, Azevedo S, Bachmann B, Back CA, Bae J, Bailey DS, Bailey J, Baisden T, Baker KL, Baldis H, Barber D, Barberis M, Barker D, Barnes A, Barnes CW, Barrios MA, Barty C, Bass I, Batha SH, Baxamusa SH, Bazan G, Beagle JK, Beale R, Beck BR, Beck JB, Bedzyk M, Beeler RG, Behrendt W, Belk L, Bell P, Belyaev M, Benage JF, Bennett G, Benedetti LR, Benedict LX, Berger R, Bernat T, Bernstein LA, Berry B, Bertolini L, Besenbruch G, Betcher J, Bettenhausen R, Betti R, Bezzerides B, Bhandarkar SD, Bickel R, Biener J, Biesiada T, Bigelow K, Bigelow-Granillo J, Bigman V, Bionta RM, Birge NW, Bitter M, Black AC, Bleile R, Bleuel DL, Bliss E, Blue B, Boehly T, Boehm K, Boley CD, Bonanno R, Bond EJ, Bond T, Bonino MJ, Borden M, Bourgade JL, Bousquet J, Bowers J, Bowers M, Boyd R, Bozek A, Bradley DK, Bradley KS, Bradley PA, Bradley L, Brannon L, Brantley PS, Braun D, Braun T, Brienza-Larsen K, Briggs TM, Britten J, Brooks ED, Browning D, Bruhn MW, Brunner TA, Bruns H, Brunton G, Bryant B, Buczek T, Bude J, Buitano L, Burkhart S, Burmark J, Burnham A, Burr R, Busby LE, Butlin B, Cabeltis R, Cable M, Cabot WH, Cagadas B, Caggiano J, Cahayag R, Caldwell SE, Calkins S, Callahan DA, Calleja-Aguirre J, Camara L, Camp D, Campbell EM, Campbell JH, Carey B, Carey R, Carlisle K, Carlson L, Carman L, Carmichael J, Carpenter A, Carr C, Carrera JA, Casavant D, Casey A, Casey DT, Castillo A, Castillo E, Castor JI, Castro C, Caughey W, Cavitt R, Celeste J, Celliers PM, Cerjan C, Chandler G, Chang B, Chang C, Chang J, Chang L, Chapman R, Chapman T, Chase L, Chen H, Chen H, Chen K, Chen LY, Cheng B, Chittenden J, Choate C, Chou J, Chrien RE, Chrisp M, Christensen K, Christensen M, Christopherson AR, Chung M, Church JA, Clark A, Clark DS, Clark K, Clark R, Claus L, Cline B, Cline JA, Cobble JA, Cochrane K, Cohen B, Cohen S, Collette MR, Collins G, Collins LA, Collins TJB, Conder A, Conrad B, Conyers M, Cook AW, Cook D, Cook R, Cooley JC, Cooper G, Cope T, Copeland SR, Coppari F, Cortez J, Cox J, Crandall DH, Crane J, Craxton RS, Cray M, Crilly A, Crippen JW, Cross D, Cuneo M, Cuotts G, Czajka CE, Czechowicz D, Daly T, Danforth P, Darbee R, Darlington B, Datte P, Dauffy L, Davalos G, Davidovits S, Davis P, Davis J, Dawson S, Day RD, Day TH, Dayton M, Deck C, Decker C, Deeney C, DeFriend KA, Deis G, Delamater ND, Delettrez JA, Demaret R, Demos S, Dempsey SM, Desjardin R, Desjardins T, Desjarlais MP, Dewald EL, DeYoreo J, Diaz S, Dimonte G, Dittrich TR, Divol L, Dixit SN, Dixon J, Dodd ES, Dolan D, Donovan A, Donovan M, D?ppner T, Dorrer C, Dorsano N, Douglas MR, Dow D, Downie J, Downing E, Dozieres M, Draggoo V, Drake D, Drake RP, Drake T, Dreifuerst G, DuBois DF, DuBois PF, Dunham G, Dylla-Spears R, Dymoke-Bradshaw AKL, Dzenitis B, Ebbers C, Eckart M, Eddinger S, Eder D, Edgell D, Edwards MJ, Efthimion P, Eggert JH, Ehrlich B, Ehrmann P, Elhadj S, Ellerbee C, Elliott NS, Ellison CL, Elsner F, Emerich M, Engelhorn K, England T, English E, Epperson P, Epstein R, Erbert G, Erickson MA, Erskine DJ, Erlandson A, Espinosa RJ, Estes C, Estabrook KG, Evans S, Fabyan A, Fair J, Fallejo R, Farmer N, Farmer WA, Farrell M, Fatherley VE, Fedorov M, Feigenbaum E, Feit M, Ferguson W, Fernandez JC, Fernandez-Panella A, Fess S, Field JE, Filip CV, Fincke JR, Finn T, Finnegan SM, Finucane RG, Fischer M, Fisher A, Fisher J, Fishler B, Fittinghoff D, Fitzsimmons P, Flegel M, Flippo KA, Florio J, Folta J, Folta P, Foreman LR, et al. Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment. Phys Rev Lett. 2022 Aug 12; 129(7):075001. PMID: [36018710](//www.ncbi.nlm.nih.gov/pubmed/36018710).

Citations:

  29. Kim SH, **Lerner SP**. Drug instillation in the management of urinary tract urothelial carcinoma. Curr Opin Urol. 2022 09 01; 32(5):531-535. PMID: [35849701](//www.ncbi.nlm.nih.gov/pubmed/35849701).

Citations:  Fields:

Uro Urology

  30. [Kamat AM](https://profiles.viictr.org/profile/12582620), Lobo N, **Lerner SP** , Li R, Matulay JT, Palou J, Witjes JA, Roupr?t M, Smith AB, Chang SS, Shore ND, Steinberg GD, [Dinney CP](https://profiles.viictr.org/profile/12583684), Svatek RS, Lamm DL. Reduced Dose Intravesical Bacillus Calmette-Gu?rin: Why It Might Not Matter. Bladder Cancer. 2022; 8(2):113-117. PMID: [38993360](//www.ncbi.nlm.nih.gov/pubmed/38993360); PMCID: [PMC11181808](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11181808).

Citations:

  31. Pal SK, Somford DM, Grivas P, Sridhar SS, Gupta S, Bellmunt J, Sonpavde G, Fleming MT, **Lerner SP** , Loriot Y, Hoffman-Censits J, Andresen C, Schnabel MJ, Cole S, Daneshmand S, Valderrama BP. Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. Future Oncol. 2022 Jul; 18(21):2599-2614. PMID: [35608106](//www.ncbi.nlm.nih.gov/pubmed/35608106).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  32. Hope TA, Knopp M, Kelly WK, Michalski JM, **Lerner SP** , Tawab-Amiri A, Mann BS, Lin DW, Yu EY, Chen RC, Beach GC, Reeves SA, Members of the Working Group, Shankar LK, Sch?der H. Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups. J Clin Oncol. 2022 05 01; 40(13):1500-1505. PMID: [35015566](//www.ncbi.nlm.nih.gov/pubmed/35015566); PMCID: [PMC9851697](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9851697).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35015566/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  33. [Matin SF](https://profiles.viictr.org/profile/12583401), Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, [Godoy G](https://profiles.viictr.org/profile/267612), Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, **Lerner SP**. Reply by Authors. J Urol. 2022 04; 207(4):788. PMID: [34985341](//www.ncbi.nlm.nih.gov/pubmed/34985341).

Citations:  Fields:

Uro Urology

  34. [Kamat AM](https://profiles.viictr.org/profile/12582620), Bivalacqua TJ, **Lerner SP** , Kassouf W, Brausi M, Buckley R, Persad R, Lamm D, Soloway M, Brothers K, Steinberg G, Lotan Y, Sylvester R, Alfred Witjes J, Black PC, Roumigui? M, B?hle A, Colombel M, Palou-Redorta J. International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Gu?rin-exposed High-risk Non-muscle-invasive Bladder Cancer. Eur Urol. 2022 07; 82(1):34-46. PMID: [34955291](//www.ncbi.nlm.nih.gov/pubmed/34955291).

Citations:  Fields:

Uro Urology

Translation:Humans

  35. Mitra AP, Narayan VM, [Mokkapati S](https://profiles.viictr.org/profile/17439977), Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, [Kamat AM](https://profiles.viictr.org/profile/12582620), Bivalacqua TJ, Montgomery JS, **Lerner SP** , Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Sawutz D, Parker NR, McConkey DJ, [Dinney CPN](https://profiles.viictr.org/profile/12583684), Yl?-Herttuala S. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 03; 81(3):223-228. PMID: [34933753](//www.ncbi.nlm.nih.gov/pubmed/34933753); PMCID: [PMC8891058](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8891058).

Citations:  Fields:

Uro Urology

Translation:Humans

  36. [Matin SF](https://profiles.viictr.org/profile/12583401), Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, [Godoy G](https://profiles.viictr.org/profile/267612), Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, **Lerner SP**. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. J Urol. 2022 Apr; 207(4):779-788. PMID: [34915741](//www.ncbi.nlm.nih.gov/pubmed/34915741).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34915741/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  37. Patel SR, **Lerner SP**. Re: Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. 2022 01; 81(1):118-119. PMID: [34799200](//www.ncbi.nlm.nih.gov/pubmed/34799200).

Citations:  Fields:

Uro Urology

Translation:Humans

  38. Chang E, Apolo AB, Bangs R, Chisolm S, Duddalwar V, Efstathiou JA, Goldberg KB, Hansel DE, [Kamat AM](https://profiles.viictr.org/profile/12582620), Kluetz PG, **Lerner SP** , Plimack E, Prowell T, Singh H, Suzman D, Yu EY, Zhang H, Beaver JA, Pazdur R, Weinstock C, Galsky MD. Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop. Nat Rev Urol. 2022 01; 19(1):37-46. PMID: [34508246](//www.ncbi.nlm.nih.gov/pubmed/34508246).

Citations:  Fields:

Uro Urology

Translation:Humans

  39. Sung HH, Scherr DS, Slaton J, Liu H, Feeny KL, Lingley-Papadopoulos C, Gearheart J, Zara JM, **Lerner SP**. Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer. Urol Oncol. 2021 07; 39(7):434.e23-434.e29. PMID: [33934964](//www.ncbi.nlm.nih.gov/pubmed/33934964).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33934964/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCTClinical Trials

  40. Patel SR, **Lerner SP**. Novel Thermo-Sensitive Hydrogel Therapy for Low-Grade Upper Tract Urothelial Carcinoma. J Urol. 2021 08; 206(2):191-193. PMID: [33787301](//www.ncbi.nlm.nih.gov/pubmed/33787301).

Citations:  Fields:

Uro Urology

Translation:Humans

  41. Meeks JJ, Sj?dahl G, **Lerner SP** , Das A, McConkey DJ, Black PC. Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment. Bladder Cancer. 2021; 7(1):1-11. PMID: [38993221](//www.ncbi.nlm.nih.gov/pubmed/38993221); PMCID: [PMC11181875](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11181875).

Citations:

  42. Shabsigh A, Kleinmann N, Smith AB, Scherr D, Seltzer E, Schoenberg M, **Lerner SP**. Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma. Cancer Chemother Pharmacol. 2021 06; 87(6):799-805. PMID: [33677615](//www.ncbi.nlm.nih.gov/pubmed/33677615); PMCID: [PMC8110485](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8110485).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33677615/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansCTClinical Trials

  43. Feldman AS, Kulkarni GS, Bivalacqua TJ, Black PC, Delacroix S, **Lerner SP** , [Kamat AM](https://profiles.viictr.org/profile/12582620), Kassouf W. Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer. Urol Oncol. 2022 10; 40(10):442-450. PMID: [33642229](//www.ncbi.nlm.nih.gov/pubmed/33642229).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33642229/citedby/) Fields:

Neo NeoplasmsUro Urology

  44. Flaig TW, Tangen CM, Daneshmand S, Alva A, **Lerner SP** , Lucia MS, McConkey DJ, Theodorescu D, Goldkorn A, Milowsky MI, Bangs R, MacVicar GR, Bastos BR, Fowles JS, Gustafson DL, Plets M, Thompson IM. A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695). Clin Cancer Res. 2021 05 01; 27(9):2435-2441. PMID: [33568346](//www.ncbi.nlm.nih.gov/pubmed/33568346); PMCID: [PMC8219246](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8219246).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33568346/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  45. Li R, **Lerner SP** , [Kamat AM](https://profiles.viictr.org/profile/12582620). The Who, What, When, Where, and Why of Bacillus Calmette-Gu?rin-unresponsive Bladder Cancer. Eur Urol. 2021 04; 79(4):437-439. PMID: [33454163](//www.ncbi.nlm.nih.gov/pubmed/33454163).

Citations:  Fields:

Uro Urology

Translation:Humans

  46. Sfakianos JP, Gul Z, Shariat SF, [Matin SF](https://profiles.viictr.org/profile/12583401), Daneshmand S, Plimack E, **Lerner S** , Pal S, Roupret M. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy. Eur Urol Oncol. 2021 04; 4(2):170-179. PMID: [33386276](//www.ncbi.nlm.nih.gov/pubmed/33386276).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33386276/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  47. Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, [Kamat AM](https://profiles.viictr.org/profile/12582620), Bivalacqua TJ, Montgomery JS, **Lerner SP** , Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, [Dinney CPN](https://profiles.viictr.org/profile/12583684). Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117. PMID: [33253641](//www.ncbi.nlm.nih.gov/pubmed/33253641); PMCID: [PMC7988888](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7988888).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33253641/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  48. Ballas L, Singh P, **Lerner SP**. Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer. Urol Oncol. 2023 01; 41(1):35-38. PMID: [33153882](//www.ncbi.nlm.nih.gov/pubmed/33153882).

Citations:  Fields:

Neo NeoplasmsUro Urology

  49. Boehm K, Thomas A, Bex A, Black PC, [Coburn M](https://profiles.viictr.org/profile/266826), Haferkamp A, Hamdy F, Kaufman RP, Klotz L, **Lerner SP** , Pushkar D, Ramon J, Rosenzweig B, Tsaur I. Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert Inquiry. Urology. 2020 11; 145:73-78. PMID: [32781078](//www.ncbi.nlm.nih.gov/pubmed/32781078); PMCID: [PMC7414774](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7414774).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32781078/citedby/) Fields:

Uro Urology

Translation:HumansCells

  50. Sung HH, **Lerner SP**. Utility of lymphadenectomy in bladder cancer: where do we stand? Curr Opin Urol. 2020 05; 30(3):407-414. PMID: [32205810](//www.ncbi.nlm.nih.gov/pubmed/32205810).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32205810/citedby/) Fields:

Uro Urology

Translation:Humans

  51. Kleinmann N, [Matin SF](https://profiles.viictr.org/profile/12583401), Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, [Godoy G](https://profiles.viictr.org/profile/267612), Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, [Adibi M](https://profiles.viictr.org/profile/17440070), Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, **Lerner SP**. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785. PMID: [32631491](//www.ncbi.nlm.nih.gov/pubmed/32631491).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32631491/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  52. [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner SP** , O'Donnell M, Georgieva MV, Yang M, Inman BA, Kassouf W, Boorjian SA, Tyson MD, Kulkarni GS, Chang SS, Konety BR, Svatek RS, Balar A, Witjes JA. Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2020 06; 3(3):318-340. PMID: [32201133](//www.ncbi.nlm.nih.gov/pubmed/32201133).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32201133/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  53. Mostafid H, Babjuk M, Bochner B, **Lerner SP** , Witjes F, Palou J, Roupret M, Shariat S, Gontero P, van Rhijn B, Zigeuner R, Sylvester R, Comperat E, Burger M, Malavaud B, Soloway M, Williams S, Black P, Daneshmand S, Steinberg G, Brausi M, Catto J, [Kamat AM](https://profiles.viictr.org/profile/12582620). Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer. Eur Urol. 2020 06; 77(6):669-670. PMID: [32192815](//www.ncbi.nlm.nih.gov/pubmed/32192815).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32192815/citedby/) Fields:

Uro Urology

Translation:Humans

  54. Robertson AG, Seiler R, Hoadley KA, Al-Ahmadie H, Choi W, Eriksson P, Mo Q, Kardos J, Zlotta A, [Dinney CP](https://profiles.viictr.org/profile/12583684), Bellmunt J, Powles T, [Chan KS](https://profiles.viictr.org/profile/266205), Kim WY, McConkey DJ, Black PC, **Lerner SP** , Real FX, Aine M, [Czerniak B](https://profiles.viictr.org/profile/12582882), Gibb EA, Kim J, Kwiatkowski DJ, Lebret T, Siefker-Radtke AA, Sirab N, Taber A, [Weinstein JN](https://profiles.viictr.org/profile/12583120), Kamoun A, de Reyni?s A, Allory Y, Sj?dahl G, Groeneveld CS, Castro MAA, Fontugne J, Hartmann A, Malats N, Dyrskj?t L, H?glund M, Radvanyi F, Bernard-Pierrot I, Liedberg F. Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5. Eur Urol. 2020 04; 77(4):436-438. PMID: [32037144](//www.ncbi.nlm.nih.gov/pubmed/32037144).

Citations:  Fields:

Uro Urology

Translation:Humans

  55. Waingankar N, Martini A, Griffiths L, Shah P, Paulucci DJ, Kotamarti S, Gul Z, Elmasri M, Yaskiv O, Haines K, **Lerner S** , Vira M, Kavoussi LR, Tewari AK, Kapoor DA, Olsson CA. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential. Urol Oncol. 2020 03; 38(3):78.e15-78.e21. PMID: [31796374](//www.ncbi.nlm.nih.gov/pubmed/31796374).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31796374/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  56. Apolo AB, Milowsky MI, Kim L, Inman BA, [Kamat AM](https://profiles.viictr.org/profile/12582620), Steinberg G, Bagheri M, Krishnasamy VP, Marko J, [Dinney CP](https://profiles.viictr.org/profile/12583684), Bangs R, Sweis RF, Maher VE, Ibrahim A, Liu K, Werntz R, Cross F, Beaver JA, Singh H, Pazdur R, Blumenthal GM, **Lerner SP** , Bajorin DF, Rosenberg JE, Agrawal S. Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. JAMA Oncol. 2019 12 01; 5(12):1790-1798. PMID: [31670753](//www.ncbi.nlm.nih.gov/pubmed/31670753); PMCID: [PMC8211913](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8211913).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31670753/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  57. Vantaku V, Amara CS, Piyarathna DWB, Donepudi SR, Ambati CR, Putluri V, Tang W, Rajapakshe K, [Estecio MR](https://profiles.viictr.org/profile/12583788), Terris MK, [Castro PD](https://profiles.viictr.org/profile/268709), [Ittmann MM](https://profiles.viictr.org/profile/269566), Williams SB, **Lerner SP** , [Sreekumar A](https://profiles.viictr.org/profile/266636), Bollag R, [Coarfa C](https://profiles.viictr.org/profile/265668), Kornberg MD, Lotan Y, Ambs S, [Putluri N](https://profiles.viictr.org/profile/269361). DNA methylation patterns in bladder tumors of African American patients point to distinct alterations in xenobiotic metabolism. Carcinogenesis. 2019 11 25; 40(11):1332-1340. PMID: [31284295](//www.ncbi.nlm.nih.gov/pubmed/31284295); PMCID: [PMC6875901](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6875901).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31284295/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  58. Kates M, Matoso A, Choi W, Baras AS, Daniels MJ, Lombardo K, Brant A, Mikkilineni N, McConkey DJ, [Kamat AM](https://profiles.viictr.org/profile/12582620), Svatek RS, Porten SP, Meeks JJ, **Lerner SP** , [Dinney CP](https://profiles.viictr.org/profile/12583684), Black PC, McKiernan JM, Anderson C, Drake CG, Bivalacqua TJ. Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials. Clin Cancer Res. 2020 02 15; 26(4):882-891. PMID: [31712383](//www.ncbi.nlm.nih.gov/pubmed/31712383).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31712383/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  59. Robertson AG, Seiler R, Hoadley KA, Al-Ahmadie H, Choi W, Eriksson P, Mo Q, Kardos J, Zlotta A, [Dinney CP](https://profiles.viictr.org/profile/12583684), Bellmunt J, Powles T, [Chan KS](https://profiles.viictr.org/profile/266205), Kim WY, McConkey DJ, Black PC, **Lerner SP** , Real FX, Bladder Cancer Molecular Taxonomy Group, Kamoun A, de Reyni?s A, Allory Y, Sj?dahl G, Groeneveld CS, Castro MAA, Fontugne J, Hartmann A, Malats N, Dyrskj?t L, H?glund M, Radvanyi F. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020 04; 77(4):420-433. PMID: [31563503](//www.ncbi.nlm.nih.gov/pubmed/31563503); PMCID: [PMC7690647](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7690647).

Citations:
[217](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31563503/citedby/)
Fields:

Uro Urology

Translation:Humans

  60. Piyarathna DWB, Rajendiran TM, Putluri V, Vantaku V, Soni T, von Rundstedt FC, Donepudi SR, Jin F, Maity S, Ambati CR, Dong J, Roth S, Degener S, Michailidis G, **Lerner SP** , Pennathur S, Lotan Y, [Coarfa C](https://profiles.viictr.org/profile/265668), [Sreekumar A](https://profiles.viictr.org/profile/266636), [Putluri N](https://profiles.viictr.org/profile/269361), G?dde D, St?rkel S. Erratum to "Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder" [Eur Urol Focus 2018;4:907-915]. Eur Urol Focus. 2019 Sep; 5(5):920. PMID: [31474581](//www.ncbi.nlm.nih.gov/pubmed/31474581).

Citations:  Fields:

Uro Urology

  61. Robinson BD, Vlachostergios PJ, Bhinder B, Liu W, Li K, Moss TJ, Bareja R, Park K, Tavassoli P, Cyrta J, Tagawa ST, Nanus DM, Beltran H, Molina AM, Khani F, Miguel Mosquera J, Xylinas E, Shariat SF, Scherr DS, Rubin MA, **Lerner SP** , [Matin SF](https://profiles.viictr.org/profile/12583401), Elemento O, Faltas BM. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun. 2019 07 05; 10(1):2977. PMID: [31278255](//www.ncbi.nlm.nih.gov/pubmed/31278255); PMCID: [PMC6611775](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6611775).

Citations:
[45](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31278255/citedby/) Fields:

Bio BiologySci Science

Translation:HumansCells

  62. Lotan Y, Boorjian SA, Zhang J, Bivalacqua TJ, Porten SP, Wheeler T, **Lerner SP** , Hutchinson R, Francis F, Davicioni E, Svatek RS, Chen CL, Black PC, Gibb EA. Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors. Eur Urol. 2019 08; 76(2):200-206. PMID: [31092337](//www.ncbi.nlm.nih.gov/pubmed/31092337).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31092337/citedby/) Fields:

Uro Urology

Translation:HumansCells

  63. Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, **Lerner SP** , Apolo AB, [Villanueva H](https://profiles.viictr.org/profile/1826409), Lee M, Sikora AG, Lotan Y, [Sreekumar A](https://profiles.viictr.org/profile/266636), [Coarfa C](https://profiles.viictr.org/profile/265668), [Putluri N](https://profiles.viictr.org/profile/269361). Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res. 2019 06 15; 25(12):3689-3701. PMID: [30846479](//www.ncbi.nlm.nih.gov/pubmed/30846479); PMCID: [PMC6571061](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6571061).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30846479/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  64. Kim J, Kwiatkowski D, McConkey DJ, Meeks JJ, Freeman SS, Bellmunt J, Getz G, **Lerner SP**. The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability. Eur Urol. 2019 06; 75(6):961-964. PMID: [30851984](//www.ncbi.nlm.nih.gov/pubmed/30851984).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30851984/citedby/) Fields:

Uro Urology

Translation:HumansCells

  65. Foerster B, D'Andrea D, Abufaraj M, Broenimann S, Karakiewicz PI, Gontero P, **Lerner SP** , Shariat SF, Soria F, Roupr?t M. Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature. Urol Oncol. 2019 07; 37(7):430-436. PMID: [30846387](//www.ncbi.nlm.nih.gov/pubmed/30846387).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30846387/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  66. Wirtz RM, Erben P, Bolenz C, Breyer J, Otto W, Hoadley KA, **Lerner SP** , Sikic D, Wach S, Dyrskj?t L, Eckstein M, Hartmann A, Keck B. Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. Transl Oncol. 2019 Apr; 12(4):661-668. PMID: [30831560](//www.ncbi.nlm.nih.gov/pubmed/30831560); PMCID: [PMC6403442](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6403442).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30831560/citedby/)

  67. **Lerner SP** , Svatek RS. What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy? Eur Urol. 2019 04; 75(4):612-614. PMID: [30616946](//www.ncbi.nlm.nih.gov/pubmed/30616946).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30616946/citedby/) Fields:

Uro Urology

Translation:Humans

  68. McConkey DJ, **Lerner SP**. SIU-ICUD consultation on bladder cancer: basic science. World J Urol. 2019 Jan; 37(1):15-29. PMID: [30547196](//www.ncbi.nlm.nih.gov/pubmed/30547196).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30547196/citedby/) Fields:

Uro Urology

Translation:HumansCells

  69. Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, **Lerner S** , Palapattu G, Wilding G, Droller M, Trump D. A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer. 2018 Oct 03; 4(Suppl 1):S1-S43. PMID: [30443561](//www.ncbi.nlm.nih.gov/pubmed/30443561); PMCID: [PMC6226303](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6226303).

Citations:

  70. Svatek RS, Tangen C, Delacroix S, Lowrance W, **Lerner SP**. Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-na?ve High-grade Non-muscle-invasive Bladder Cancer. Eur Urol Focus. 2018 07; 4(4):522-524. PMID: [30197040](//www.ncbi.nlm.nih.gov/pubmed/30197040); PMCID: [PMC6581029](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6581029).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30197040/citedby/) Fields:

Uro Urology

Translation:HumansCellsCTClinical Trials

  71. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, [Akbani R](https://profiles.viictr.org/profile/12583156), Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, [Czerniak BA](https://profiles.viictr.org/profile/12582882), Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, [Mills GB](https://profiles.viictr.org/profile/12582930), McConkey DJ, TCGA Research Network, [Weinstein JN](https://profiles.viictr.org/profile/12583120), Kwiatkowski DJ, **Lerner SP**. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2018 08 09; 174(4):1033. PMID: [30096301](//www.ncbi.nlm.nih.gov/pubmed/30096301); PMCID: [PMC6297116](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6297116).

Citations:
[111](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30096301/citedby/)
Fields:

Cel Cell Biology

  72. Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, **Lerner S** , Montironi R, Muglia VF, Salomon G, Thomas S, Vargas HA, Witjes JA, Takeuchi M, Barentsz J, Catto JWF. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018 09; 74(3):294-306. PMID: [29755006](//www.ncbi.nlm.nih.gov/pubmed/29755006); PMCID: [PMC6690492](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6690492).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29755006/citedby/) Fields:

Uro Urology

Translation:Humans

  73. Messing EM, Tangen CM, **Lerner SP** , Sahasrabudhe DM, Koppie TM, Wood DP, Mack PC, Svatek RS, Evans CP, Hafez KS, Culkin DJ, Brand TC, Karsh LI, Holzbeierlein JM, Wilson SS, Wu G, Plets M, Vogelzang NJ, Thompson IM. Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial. JAMA. 2018 05 08; 319(18):1880-1888. PMID: [29801011](//www.ncbi.nlm.nih.gov/pubmed/29801011); PMCID: [PMC6583489](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6583489).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29801011/citedby/) Fields:

Med Medicine (General)

Translation:HumansCTClinical Trials

  74. Ku JH, Yuk HD, Godoy G, Amiel GE, **Lerner SP**. Prognostication in Patients Treated with Radical Cystectomy for Urothelial Bladder Carcinoma: A New Simplified Model Incorporating Histological Variants. Bladder Cancer. 2018 Apr 26; 4(2):195-203. PMID: [29732390](//www.ncbi.nlm.nih.gov/pubmed/29732390); PMCID: [PMC5929296](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5929296).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29732390/citedby/)

  75. Tu H, [Dinney CP](https://profiles.viictr.org/profile/12583684), [Ye Y](https://profiles.viictr.org/profile/12583090), Grossman HB, **Lerner SP** , Wu X. Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study. Am J Clin Nutr. 2018 02 01; 107(2):208-216. PMID: [29529165](//www.ncbi.nlm.nih.gov/pubmed/29529165); PMCID: [PMC6669327](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6669327).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29529165/citedby/) Fields:

Nut Nutritional Sciences

Translation:Humans

  76. Westhoff E, Witjes JA, Fleshner NE, **Lerner SP** , Shariat SF, Steineck G, Kampman E, Kiemeney LA, Vrieling A. Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis. Bladder Cancer. 2018 Jan 20; 4(1):91-112. PMID: [29430510](//www.ncbi.nlm.nih.gov/pubmed/29430510); PMCID: [PMC5798521](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5798521).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29430510/citedby/)

  77. **Lerner SP** , Rodriguez-Vida A, Bellmunt J. The Cancer Genome Atlas Project in Bladder Cancer. Cancer Treat Res. 2018; 175:259-271. PMID: [30168126](//www.ncbi.nlm.nih.gov/pubmed/30168126).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30168126/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  78. Westhoff E, Wu X, Kiemeney LA, **Lerner SP** , Ye Y, Huang M, [Dinney CP](https://profiles.viictr.org/profile/12583684), Vrieling A, Tu H. Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer. Int J Cancer. 2018 05 01; 142(9):1797-1804. PMID: [29235103](//www.ncbi.nlm.nih.gov/pubmed/29235103).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29235103/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  79. Meeks JJ, **Lerner SP**. Molecular Landscape of Non-Muscle Invasive Bladder Cancer. Cancer Cell. 2017 11 13; 32(5):550-551. PMID: [29136502](//www.ncbi.nlm.nih.gov/pubmed/29136502).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29136502/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  80. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, [Akbani R](https://profiles.viictr.org/profile/12583156), Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, [Czerniak BA](https://profiles.viictr.org/profile/12582882), Reuter VE, Su X, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, [Mills GB](https://profiles.viictr.org/profile/12582930), McConkey DJ, TCGA Research Network, Kwiatkowski DJ, **Lerner SP** , Castro MAA, de Sa Carvalho B, Chagas VS, [Weinstein JN](https://profiles.viictr.org/profile/12583120). Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017 Oct 19; 171(3):540-556.e25. PMID: [28988769](//www.ncbi.nlm.nih.gov/pubmed/28988769); PMCID: [PMC5687509](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5687509).

Citations:
[661](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28988769/citedby/)
Fields:

Cel Cell Biology

Translation:HumansCells

  81. Jin F, Thaiparambil J, Donepudi SR, Vantaku V, Piyarathna DWB, Maity S, Krishnapuram R, Putluri V, Gu F, Purwaha P, Bhowmik SK, Ambati CR, von Rundstedt FC, Roghmann F, Berg S, Noldus J, Rajapakshe K, Roth S, Degener S, Michailidis G, [Kaipparettu BA](https://profiles.viictr.org/profile/269257), Karanam B, Terris MK, Kavuri SM, **Lerner SP** , [Kheradmand F](https://profiles.viictr.org/profile/270223), [Coarfa C](https://profiles.viictr.org/profile/265668), [Sreekumar A](https://profiles.viictr.org/profile/266636), Lotan Y, El-Zein R, [Putluri N](https://profiles.viictr.org/profile/269361), G?dde D, St?rkel S. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer. Cancer Prev Res (Phila). 2017 Oct; 10(10):588-597. PMID: [28851690](//www.ncbi.nlm.nih.gov/pubmed/28851690); PMCID: [PMC5626664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5626664).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28851690/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  82. Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, [Kamat AM](https://profiles.viictr.org/profile/12582620), Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL, Krupski TL, **Lerner SP** , Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, [Dinney CPN](https://profiles.viictr.org/profile/12583684). Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416. PMID: [28834453](//www.ncbi.nlm.nih.gov/pubmed/28834453); PMCID: [PMC5648171](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28834453/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  83. Chang SS, Bochner BH, Chou R, Dreicer R, [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner SP** , Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM. Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2017 09; 13(9):621-625. PMID: [28796558](//www.ncbi.nlm.nih.gov/pubmed/28796558).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28796558/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  84. **Lerner SP** , Theodorescu D. New Sister Journal Kidney Cancer. Bladder Cancer. 2017 Jul 27; 3(3):143. PMID: [28824939](//www.ncbi.nlm.nih.gov/pubmed/28824939); PMCID: [PMC5545903](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5545903).

Citations:

  85. [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner S** , Black P, Bellmunt J, [Dinney C](https://profiles.viictr.org/profile/12583684), Hahn NM, O'Donnell M, Quale DZ. Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer. Bladder Cancer. 2017 Jul 27; 3(3):145-146. PMID: [28824940](//www.ncbi.nlm.nih.gov/pubmed/28824940); PMCID: [PMC5545902](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5545902).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28824940/citedby/)

  86. Shen S, **Lerner SP**. Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy". Bladder Cancer. 2017 Jul 27; 3(3):171-172. PMID: [28824944](//www.ncbi.nlm.nih.gov/pubmed/28824944); PMCID: [PMC5545913](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5545913).

Citations:

  87. Moss TJ, Qi Y, Xi L, [Peng B](https://profiles.viictr.org/profile/30797003), Kim TB, Ezzedine NE, Mosqueda ME, [Guo CC](https://profiles.viictr.org/profile/12583087), [Czerniak BA](https://profiles.viictr.org/profile/12582882), [Ittmann M](https://profiles.viictr.org/profile/269566), [Wheeler DA](https://profiles.viictr.org/profile/266937), **Lerner SP** , [Matin SF](https://profiles.viictr.org/profile/12583401). Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol. 2017 10; 72(4):641-649. PMID: [28601352](//www.ncbi.nlm.nih.gov/pubmed/28601352).

Citations:
[67](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28601352/citedby/) Fields:

Uro Urology

Translation:Humans

  88. Chang SS, Bochner BH, Chou R, Dreicer R, [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner SP** , Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017 09; 198(3):552-559. PMID: [28456635](//www.ncbi.nlm.nih.gov/pubmed/28456635); PMCID: [PMC5626446](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5626446).

Citations:
[160](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28456635/citedby/)
Fields:

Uro Urology

Translation:Humans

  89. Piyarathna DWB, Rajendiran TM, Putluri V, Vantaku V, Soni T, von Rundstedt FC, Donepudi SR, Jin F, Maity S, Ambati CR, Dong J, Roth S, Degener S, Michailidis G, **Lerner SP** , Pennathur S, Lotan Y, [Coarfa C](https://profiles.viictr.org/profile/265668), [Sreekumar A](https://profiles.viictr.org/profile/266636), [Putluri N](https://profiles.viictr.org/profile/269361), G?dde D, St?rkel S. Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus. 2018 12; 4(6):907-915. PMID: [28753886](//www.ncbi.nlm.nih.gov/pubmed/28753886); PMCID: [PMC5650548](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5650548).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28753886/citedby/) Fields:

Uro Urology

Translation:Humans

  90. Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Kardos J, Hoadley KA, **Lerner SP** , McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden MS, Black PC, Sj?dahl G, Todenh?fer T. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy. Eur Urol. 2017 10; 72(4):544-554. PMID: [28390739](//www.ncbi.nlm.nih.gov/pubmed/28390739).

Citations:
[240](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28390739/citedby/)
Fields:

Uro Urology

Translation:HumansCells

  91. Choi W, Ochoa A, McConkey DJ, Aine M, Kim WY, Kiltie AE, Milsom I, **Lerner SP** , H?glund M, Real FX, Dyrskj?t L. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol. 2017 09; 72(3):354-365. PMID: [28365159](//www.ncbi.nlm.nih.gov/pubmed/28365159); PMCID: [PMC5764190](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5764190).

Citations:
[75](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28365159/citedby/) Fields:

Uro Urology

Translation:Humans

  92. von Rundstedt FC, Mata DA, Kryvenko ON, Shah AA, Jhun I, **Lerner SP**. Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study. Bladder Cancer. 2017 Jan 27; 3(1):35-44. PMID: [28149933](//www.ncbi.nlm.nih.gov/pubmed/28149933); PMCID: [PMC5271426](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5271426).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28149933/citedby/)

  93. Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, [Caraway NP](https://profiles.viictr.org/profile/12582519), Huang L, Shoshan E, Velazquez-Torres G, Nitti G, Lee S, Lee JG, [Fuentes-Mattei E](https://profiles.viictr.org/profile/17440023), Willis D, Zhang L, [Guo CC](https://profiles.viictr.org/profile/12583087), Yao H, [Baggerly K](https://profiles.viictr.org/profile/12582600), Lotan Y, **Lerner SP** , [Dinney C](https://profiles.viictr.org/profile/12583684), McConkey D, Bar-Eli M, [Czerniak B](https://profiles.viictr.org/profile/12582882). Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep. 2017 01 19; 7:40714. PMID: [28102366](//www.ncbi.nlm.nih.gov/pubmed/28102366); PMCID: [PMC5244380](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5244380).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28102366/citedby/) Fields:

Sci Science

Translation:HumansCells

  94. Meeks JJ, **Lerner SP** , Svatek RS. Bacillus Calmette-Gu?rin Manufacturing and SWOG S1602 Intergroup Clinical Trial. J Urol. 2017 03; 197(3 Pt 1):538-540. PMID: [27992750](//www.ncbi.nlm.nih.gov/pubmed/27992750).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27992750/citedby/) Fields:

Uro Urology

Translation:Humans

  95. Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC, Xiao J, Kurtova A, **Lerner S** , [Godoy G](https://profiles.viictr.org/profile/267612), Jian W, [Castro P](https://profiles.viictr.org/profile/268709), Chen F, [Rowley D](https://profiles.viictr.org/profile/269631), [Ittmann M](https://profiles.viictr.org/profile/269566), [Chan KS](https://profiles.viictr.org/profile/266205). Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. 2016 Dec 13; 7(50):82609-82619. PMID: [27655672](//www.ncbi.nlm.nih.gov/pubmed/27655672); PMCID: [PMC5347718](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5347718).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27655672/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  96. von Rundstedt FC, Mata DA, Shen S, Li Y, [Godoy G](https://profiles.viictr.org/profile/267612), **Lerner SP**. Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomy. J Clin Urol. 2016 Nov; 9(6):404-408. PMID: [27818773](//www.ncbi.nlm.nih.gov/pubmed/27818773); PMCID: [PMC5096792](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5096792).

Citations:

  97. Ojerholm E, Smith A, Hwang WT, Baumann BC, Tucker KN, **Lerner SP** , Mamtani R, Boursi B, Christodouleas JP. Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. Cancer. 2017 Mar 01; 123(5):794-801. PMID: [27787873](//www.ncbi.nlm.nih.gov/pubmed/27787873); PMCID: [PMC5319875](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5319875).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27787873/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  98. Ku JH, Kim WJ, **Lerner SP** , Chun F, Kluth LA. Diagnostic and Prognostic Markers in Bladder Cancer. Dis Markers. 2016; 2016:2425091. PMID: [27795607](//www.ncbi.nlm.nih.gov/pubmed/27795607); PMCID: [PMC5067309](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5067309).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27795607/citedby/) Fields:

Bio Biochemistry

Translation:Humans

  99. Soria F, Shariat SF, **Lerner SP** , Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Kikuchi E, Babjuk M, Grollman AP, Thalmann GN, Fern?ndez MI, Chade DC. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017 Mar; 35(3):379-387. PMID: [27604375](//www.ncbi.nlm.nih.gov/pubmed/27604375).

Citations:
[72](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27604375/citedby/) Fields:

Uro Urology

Translation:Humans

  100. Barbieri CE, Chinnaiyan AM, **Lerner SP** , Swanton C, Rubin MA. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics. Eur Urol. 2017 02; 71(2):237-246. PMID: [27567210](//www.ncbi.nlm.nih.gov/pubmed/27567210); PMCID: [PMC5195855](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5195855).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27567210/citedby/) Fields:

Uro Urology

Translation:Humans

  101. **Lerner SP** , Robertson AG. Molecular Subtypes of Non-muscle Invasive Bladder Cancer. Cancer Cell. 2016 07 11; 30(1):1-3. PMID: [27411578](//www.ncbi.nlm.nih.gov/pubmed/27411578).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27411578/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  102. **Lerner SP**. Bladder cancer: ASCO endorses EAU muscle-invasive bladder cancer guidelines. Nat Rev Urol. 2016 08; 13(8):440-1. PMID: [27377160](//www.ncbi.nlm.nih.gov/pubmed/27377160).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27377160/citedby/) Fields:

Uro Urology

Translation:Humans

  103. [Kamat AM](https://profiles.viictr.org/profile/12582620), Hahn NM, Efstathiou JA, **Lerner SP** , [Choi W](https://profiles.viictr.org/profile/12583772), [Guo CC](https://profiles.viictr.org/profile/12583087), Lotan Y, Kassouf W, Malmstr?m PU. Bladder cancer. Lancet. 2016 12 03; 388(10061):2796-2810. PMID: [27345655](//www.ncbi.nlm.nih.gov/pubmed/27345655).

Citations:
[407](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27345655/citedby/)
Fields:

Med Medicine (General)

Translation:Humans

  104. **Lerner SP** , Bajorin DF, [Dinney CP](https://profiles.viictr.org/profile/12583684), Efstathiou JA, Groshen S, Hahn NM, Hansel D, Kwiatkowski D, O'Donnell M, Rosenberg J, Svatek R, Abrams JS, Al-Ahmadie H, Apolo AB, Bellmunt J, Callahan M, Cha EK, Drake C, Jarow J, [Kamat A](https://profiles.viictr.org/profile/12582620), Kim W, Knowles M, Mann B, Marchionni L, McConkey D, McShane L, Ramirez N, Sharabi A, Sharpe AH, Solit D, Tangen CM, Amiri AT, Van Allen E, West PJ, Witjes JA, Quale DZ. Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2016 Apr 27; 2(2):165-202. PMID: [27376138](//www.ncbi.nlm.nih.gov/pubmed/27376138); PMCID: [PMC4927845](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927845).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27376138/citedby/)

  105. Pal SK, Pham A, Vuong W, Liu X, Lin Y, Ruel N, Yuh BE, Chan K, Wilson T, **Lerner SP** , McConkey D, Jove R, Liang W. Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017 02; 3(1):130-135. PMID: [28720358](//www.ncbi.nlm.nih.gov/pubmed/28720358).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28720358/citedby/) Fields:

Uro Urology

Translation:HumansCells

  106. Calderone CE, **Lerner SP** , [Taylor JM](https://profiles.viictr.org/profile/9833234). The case for salvage cystectomy after pelvic radiation. Minerva Urol Nefrol. 2016 Apr; 68(2):161-71. PMID: [26982375](//www.ncbi.nlm.nih.gov/pubmed/26982375).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26982375/citedby/) Fields:

Nep NephrologyUro Urology

Translation:Humans

  107. Falchi L, Vitale C, Keating MJ, **Lerner S** , Wang X, Elhor Gbito KY, Strom S, [Wierda WG](https://profiles.viictr.org/profile/12582613), [Ferrajoli A](https://profiles.viictr.org/profile/12583717). Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia. Ann Oncol. 2016 06; 27(6):1100-1106. PMID: [26912560](//www.ncbi.nlm.nih.gov/pubmed/26912560); PMCID: [PMC4880062](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4880062).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26912560/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  108. Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Herr HW, **Lerner SP** , Guzzo TJ, Malkowicz SB, Christodouleas JP. Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):703-6. PMID: [27020106](//www.ncbi.nlm.nih.gov/pubmed/27020106); PMCID: [PMC5126649](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5126649).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27020106/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  109. von Rundstedt FC, Rajapakshe K, Ma J, Arnold JM, Gohlke J, Putluri V, Krishnapuram R, Piyarathna DB, Lotan Y, Roth S, Levitt JM, Michailidis G, [Sreekumar A](https://profiles.viictr.org/profile/266636), **Lerner SP** , [Coarfa C](https://profiles.viictr.org/profile/265668), [Putluri N](https://profiles.viictr.org/profile/269361), G?dde D, St?rkel S. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival. J Urol. 2016 06; 195(6):1911-9. PMID: [26802582](//www.ncbi.nlm.nih.gov/pubmed/26802582); PMCID: [PMC4861129](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4861129).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26802582/citedby/) Fields:

Uro Urology

Translation:HumansCells

  110. **Lerner SP** , McConkey DJ, Hoadley KA, [Chan KS](https://profiles.viictr.org/profile/266205), Kim WY, Radvanyi F, H?glund M, Real FX. Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting. Bladder Cancer. 2016 Jan 07; 2(1):37-47. PMID: [27376123](//www.ncbi.nlm.nih.gov/pubmed/27376123); PMCID: [PMC4927916](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927916).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27376123/citedby/)

  111. **Lerner SP**. Editorial Comment. J Urol. 2016 Jan; 195(1):59. PMID: [26475224](//www.ncbi.nlm.nih.gov/pubmed/26475224).

Citations:  Fields:

Uro Urology

Translation:Humans

  112. Kim J, [Akbani R](https://profiles.viictr.org/profile/12583156), [Creighton CJ](https://profiles.viictr.org/profile/265729), **Lerner SP** , [Weinstein JN](https://profiles.viictr.org/profile/12583120), Getz G, Kwiatkowski DJ. Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise. Clin Cancer Res. 2015 Oct 15; 21(20):4514-24. PMID: [26473186](//www.ncbi.nlm.nih.gov/pubmed/26473186); PMCID: [PMC4610178](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4610178).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26473186/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  113. Hahn NM, Knudsen BS, Daneshmand S, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Liu Z, Breen T, Fleming MT, Lance R, Corless CL, Alva AS, Shen SS, Huang F, Gertych A, [Gallick GE](https://profiles.viictr.org/profile/12583655), Mallick J, Ryan C, Galsky MD, **Lerner SP** , Posadas EM, Sonpavde G. Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. Urol Oncol. 2016 Jan; 34(1):4.e11-7. PMID: [26362343](//www.ncbi.nlm.nih.gov/pubmed/26362343).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26362343/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCTClinical Trials

  114. Brooks M, [Godoy G](https://profiles.viictr.org/profile/267612), Shariat SF, Amiel GE, **Lerner SP** , Sun M. External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy. J Urol. 2016 Feb; 195(2):283-9. PMID: [26343350](//www.ncbi.nlm.nih.gov/pubmed/26343350); PMCID: [PMC6289832](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6289832).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26343350/citedby/) Fields:

Uro Urology

Translation:Humans

  115. **Lerner SP**. Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer. Eur Urol Focus. 2015 Aug; 1(1):94-95. PMID: [26478915](//www.ncbi.nlm.nih.gov/pubmed/26478915); PMCID: [PMC4602408](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4602408).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26478915/citedby/) Fields:

Uro Urology

  116. **Lerner SP** , [Weinstein J](https://profiles.viictr.org/profile/12583120), Kwiatkowski D, Kim J, Robertson G, Hoadley KA, [Akbani R](https://profiles.viictr.org/profile/12583156), [Creighton C](https://profiles.viictr.org/profile/265729), TCGA Muscle Invasive Bladder Cancer Analysis Working Group. The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer. Eur Urol Focus. 2015 Aug; 1(1):94-95. PMID: [28723366](//www.ncbi.nlm.nih.gov/pubmed/28723366).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28723366/citedby/) Fields:

Uro Urology

  117. von Rundstedt FC, **Lerner SP**. Bacille-Calmette-Guerin non-responders: how to manage. Transl Androl Urol. 2015 Jun; 4(3):244-53. PMID: [26816828](//www.ncbi.nlm.nih.gov/pubmed/26816828); PMCID: [PMC4708234](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4708234).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26816828/citedby/)

  118. Joo KJ, Li H, Zhang X, **Lerner SP**. Therapeutic Effect on Bladder Cancer with a?Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex Virus. Bladder Cancer. 2015 Apr 30; 1(1):81-90. PMID: [30561438](//www.ncbi.nlm.nih.gov/pubmed/30561438); PMCID: [PMC6218184](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6218184).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30561438/citedby/)

  119. Mata DA, Groshen S, Von Rundstedt FC, Skinner DG, Stadler WM, Cote RJ, Stein JP, **Lerner SP**. Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol. 2015 Jun; 111(7):923-8. PMID: [25873574](//www.ncbi.nlm.nih.gov/pubmed/25873574); PMCID: [PMC4602027](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4602027).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25873574/citedby/) Fields:

Gen General SurgeryNeo Neoplasms

Translation:HumansCTClinical Trials

  120. Preston MA, **Lerner SP** , Kibel AS. New trends in the surgical management of invasive bladder cancer. Hematol Oncol Clin North Am. 2015 Apr; 29(2):253-69, viii. PMID: [25836933](//www.ncbi.nlm.nih.gov/pubmed/25836933).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25836933/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  121. **Lerner SP** , [Dinney C](https://profiles.viictr.org/profile/12583684), [Kamat A](https://profiles.viictr.org/profile/12582620), Bivalacqua TJ, Nielsen M, O'Donnell M, Schoenberg MP, Steinberg G. Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG. Bladder Cancer. 2015 Mar 30; 1(1):29-30. PMID: [26807434](//www.ncbi.nlm.nih.gov/pubmed/26807434); PMCID: [PMC4720147](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4720147).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26807434/citedby/)

  122. von Rundstedt FC, Mata DA, Groshen S, Stein JP, Skinner DG, Stadler WM, Cote RJ, Kryvenko ON, [Godoy G](https://profiles.viictr.org/profile/267612), **Lerner SP**. Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial. BJU Int. 2015 Jul; 116(1):44-9. PMID: [25413313](//www.ncbi.nlm.nih.gov/pubmed/25413313); PMCID: [PMC4524781](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4524781).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25413313/citedby/) Fields:

Uro Urology

Translation:Humans

  123. Mitra AP, **Lerner SP**. Potential role for targeted therapy in muscle-invasive bladder cancer: lessons from the cancer genome atlas and beyond. Urol Clin North Am. 2015 May; 42(2):201-15, viii. PMID: [25882562](//www.ncbi.nlm.nih.gov/pubmed/25882562).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25882562/citedby/) Fields:

Uro Urology

Translation:Humans

  124. Kluth LA, Black PC, Bochner BH, Catto J, **Lerner SP** , Stenzl A, Sylvester R, Vickers AJ, Shariat SF, Xylinas E. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. Eur Urol. 2015 Aug; 68(2):238-53. PMID: [25709027](//www.ncbi.nlm.nih.gov/pubmed/25709027).

Citations:
[102](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25709027/citedby/)
Fields:

Uro Urology

Translation:Humans

  125. Fritsche HM, Burger M, Svatek RS, Novara G, Skinner E, Denzinger S, Isbarn H, Volkmer BG, Montorsi F, Otto W, Izawa JI, Ficarra V, **Lerner S** , Sagalowsky AI, Schoenberg M, [Kamat A](https://profiles.viictr.org/profile/12582620), [Dinney CP](https://profiles.viictr.org/profile/12583684), Lotan Y, Shariat SF, Jeldres C, Karakiewicz PI, Fradet Y, Bastian PJ, Kassouf W, Tilki D, Capitanio U. Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. Eur Urol. 2015 Jul; 68(1):171. PMID: [26088736](//www.ncbi.nlm.nih.gov/pubmed/26088736).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26088736/citedby/) Fields:

Uro Urology

  126. Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, **Lerner SP** , Chen F, Roh TT, Lay E, Ho PL, [Chan KS](https://profiles.viictr.org/profile/266205). Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 2015 Jan 08; 517(7533):209-13. PMID: [25470039](//www.ncbi.nlm.nih.gov/pubmed/25470039); PMCID: [PMC4465385](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4465385).

Citations:
[253](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25470039/citedby/)
Fields:

Sci Science

Translation:HumansAnimalsCells

  127. Kowalkowski MA, Petersen NJ, Amiel GE, **Lerner SP** , [Latini DM](https://profiles.viictr.org/profile/265641), Goltz HH. Educational opportunities in bladder cancer: increasing cystoscopic adherence and the availability of smoking-cessation programs. J Cancer Educ. 2014 Dec; 29(4):739-45. PMID: [24719024](//www.ncbi.nlm.nih.gov/pubmed/24719024); PMCID: [PMC4412159](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4412159).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24719024/citedby/) Fields:

Edu EducationNeo Neoplasms

Translation:Humans

  128. El-Sayed Ahmed MM, Aftab M, Al-Najjar RM, de la Cruz KI, **Lerner SP** , [Coselli JS](https://profiles.viictr.org/profile/267370). Renal cell carcinoma extending into the retrohepatic inferior vena cava. Tex Heart Inst J. 2014 Dec; 41(6):671-2. PMID: [25593540](//www.ncbi.nlm.nih.gov/pubmed/25593540); PMCID: [PMC4251347](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4251347).

Citations:  Fields:

Car Cardiology

Translation:Humans

  129. [Dinney CP](https://profiles.viictr.org/profile/12583684), Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, **Lerner S** , [Czerniak B](https://profiles.viictr.org/profile/12582882), Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urol Oncol. 2014 Nov; 32(8):1108-15. PMID: [25443274](//www.ncbi.nlm.nih.gov/pubmed/25443274); PMCID: [PMC4262150](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4262150).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25443274/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  130. **Lerner SP**. Targeted therapies for metastatic bladder cancer. J Urol. 2015 Jan; 193(1):8-9. PMID: [25444968](//www.ncbi.nlm.nih.gov/pubmed/25444968).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25444968/citedby/) Fields:

Uro Urology

Translation:Humans

  131. Jian W, Xu HG, Chen J, Xu ZX, Levitt JM, Stanley JA, Yang ES, **Lerner SP** , Sonpavde G. Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage. Anticancer Drugs. 2014 Sep; 25(8):878-86. PMID: [24714082](//www.ncbi.nlm.nih.gov/pubmed/24714082).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24714082/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansAnimalsCells

  132. von Rundstedt FC, **Lerner SP**. New imaging techniques for nonmuscle invasive bladder cancer. Curr Opin Urol. 2014 Sep; 24(5):532-9. PMID: [25051025](//www.ncbi.nlm.nih.gov/pubmed/25051025).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25051025/citedby/) Fields:

Uro Urology

Translation:Humans

  133. von Rundstedt FC, **Lerner SP** , [Godoy G](https://profiles.viictr.org/profile/267612), Amiel G, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Truong LD](https://profiles.viictr.org/profile/267800), Shen SS. Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy. J Urol. 2015 Jan; 193(1):58-63. PMID: [25106902](//www.ncbi.nlm.nih.gov/pubmed/25106902); PMCID: [PMC4524785](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4524785).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25106902/citedby/) Fields:

Uro Urology

Translation:Humans

  134. **Lerner SP** , Goh A. Novel endoscopic diagnosis for bladder cancer. Cancer. 2015 Jan 15; 121(2):169-78. PMID: [25132313](//www.ncbi.nlm.nih.gov/pubmed/25132313).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25132313/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  135. Jarow J, Kluetz PG, **Lerner SP** , Liu K, Sridhara R, Bajorin D, Chang S, [Dinney CP](https://profiles.viictr.org/profile/12583684), Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B. Reply by the authors. Urology. 2014 Aug; 84(2):495-6. PMID: [25065996](//www.ncbi.nlm.nih.gov/pubmed/25065996).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25065996/citedby/) Fields:

Uro Urology

Translation:Humans

  136. Kowalkowski MA, Chandrashekar A, Amiel GE, **Lerner SP** , Wittmann DA, [Latini DM](https://profiles.viictr.org/profile/265641), Goltz HH. Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research. Sex Med. 2014 Aug; 2(3):141-51. PMID: [25356311](//www.ncbi.nlm.nih.gov/pubmed/25356311); PMCID: [PMC4184494](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4184494).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25356311/citedby/)

  137. Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, Ahlbom A, Albanes D, Allen NE, Ambrosone CB, Aldrich M, Amiano P, [Amos C](https://profiles.viictr.org/profile/23372697), Andersson U, Andriole G, Andrulis IL, Arici C, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Beane Freeman LE, Berg CD, Berndt SI, Bertazzi PA, Biritwum RB, Black A, Blot W, Boeing H, Boffetta P, Bolton K, Boutron-Ruault MC, Bracci PM, Brennan P, Brinton LA, Brotzman M, Bueno-de-Mesquita HB, Buring JE, Butler MA, Cai Q, Canzian F, Cao G, Caporaso NE, Carreon T, Carta A, Chang GC, Chang IS, Chang-Claude J, Che X, Chen CJ, Chen CY, Chen CH, Chen C, Chen KY, Chen YM, Chokkalingam AP, Chu LW, Clavel-Chapelon F, Colditz GA, Colt JS, Conti D, Cook MB, Cortessis VK, Crawford ED, Davis FG, De Vivo I, Deng X, Ding T, [Dinney CP](https://profiles.viictr.org/profile/12583684), Di Stefano AL, Diver WR, Duell EJ, Elena JW, Fan JH, Feigelson HS, Feychting M, Figueroa JD, Flanagan AM, Fraumeni JF, Freedman ND, Fridley BL, Fuchs CS, Gallinger S, Gapstur SM, Garcia-Closas M, [Gastier-Foster JM](https://profiles.viictr.org/profile/29494220), Gaziano JM, Gerhard DS, Giffen CA, Giles GG, Gillanders EM, Giovannucci EL, Goggins M, Gokgoz N, Goldstein AM, Gonzalez C, Gorlick R, Greene MH, Gross M, Grossman HB, Grubb R, Gu J, Guan P, Haiman CA, Hallmans G, Hankinson SE, Harris CC, Hartge P, Hattinger C, Hayes RB, He Q, Helman L, Henderson BE, Henriksson R, Hoffman-Bolton J, Hohensee C, Holly EA, Hong YC, Hoover RN, Hosgood HD, Hsiao CF, Hsing AW, Hsiung CA, Hu N, Hu W, Hu Z, Huang MS, Hunter DJ, Inskip PD, Ito H, Jacobs EJ, Jacobs KB, Jenab M, Ji BT, Johansen C, Johansson M, Johnson A, Kaaks R, [Kamat AM](https://profiles.viictr.org/profile/12582620), Kamineni A, Karagas M, Khanna C, Khaw KT, Kim C, Kim IS, Kim JH, Kim YH, Kim YC, Kim YT, Kang CH, Jung YJ, Kitahara CM, Klein AP, Klein R, Koh WP, Kohno T, Kolonel LN, Kooperberg C, Kratz CP, Krogh V, Kunitoh H, Kurtz RC, Kurucu N, Lan Q, Lau CC, Lecanda F, Lee KM, Lee MP, Le Marchand L, **Lerner SP** , Li D, Liao LM, Lim WY, Lin D, Lin J, Lindstrom S, Linet MS, Lissowska J, Liu J, Lu D, Ma J, Mannisto S, Marina N, Mastrangelo G, Matsuo K, McGlynn KA, McKean-Cowdin R, [McNeill LH](https://profiles.viictr.org/profile/12582727), McWilliams RR, Melin BS, Meltzer PS, Mensah JE, Miao X, Michaud DS, Mondul AM, Moore LE, Muir K, Niwa S, Olson SH, Orr N, Panico S, Park JY, Patel AV, Patino-Garcia A, Pavanello S, Peeters PH, Peplonska B, Peters U, Petersen GM, Picci P, Pike MC, Porru S, Prescott J, Pu X, Purdue MP, Qiao YL, Rajaraman P, Riboli E, Risch HA, Rodabough RJ, Rothman N, Ruder AM, Ryu JS, Sanson M, Schned A, Schumacher FR, Schwartz AG, Schwartz KL, Schwenn M, Scotlandi K, Seow A, Serra C, Serra M, Sesso HD, Severi G, Shen H, Shen M, [Shete S](https://profiles.viictr.org/profile/12583745), Shiraishi K, Shu XO, Siddiq A, Sierrasesumaga L, Sierri S, Loon Sihoe AD, Silverman DT, Simon M, Southey MC, Spector L, [Spitz M](https://profiles.viictr.org/profile/266382), Stampfer M, Stattin P, Stern MC, Stevens VL, Stolzenberg-Solomon RZ, Stram DO, Strom SS, Su WC, Sung SW, Swerdlow A, Tan W, Tanaka H, Tang W, Tang ZZ, Tay E, Taylor PR, Tettey Y, Thomas DM, Tirabosco R, Tjonneland A, Tobias GS, Toro JR, Travis RC, Trichopoulos D, Troisi R, Truelove A, Tsai YH, Tucker MA, Tumino R, Van Den Berg D, Van Den Eeden SK, Vermeulen R, Vineis P, Visvanathan K, Vogel U, Wang C, Wang C, Wang J, Wang SS, Weinstein SJ, Wentzensen N, Wheeler W, White E, Wiencke JK, Wolk A, Wolpin BM, Wong MP, Wrensch M, Wu C, Wu T, Wu X, Wu YL, Wunder JS, Xu J, Yang HP, Yang PC, Yatabe Y, Ye Y, Yeboah ED, Yin Z, Ying C, Yu CJ, Yu K, Yuan JM, Zanetti KA, Zeleniuch-Jacquotte A, Zheng W, Zhou B, Mirabello L, Savage SA, Kraft P, Chanock SJ, Yeager M, Landi MT, Shi J, Chatterjee N, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33. PMID: [25027329](//www.ncbi.nlm.nih.gov/pubmed/25027329); PMCID: [PMC4240198](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4240198).

Citations:
[62](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25027329/citedby/) Fields:

Gen GeneticsMol Molecular Biology

Translation:HumansCells

  138. Jian W, Levitt JM, **Lerner SP** , Sonpavde G. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3377-82. PMID: [24982343](//www.ncbi.nlm.nih.gov/pubmed/24982343).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24982343/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  139. Jian W, Levitt JM, **Lerner SP** , Sonpavde G. The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9. PMID: [24982344](//www.ncbi.nlm.nih.gov/pubmed/24982344).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24982344/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  140. Messer JC, Shariat SF, [Dinney CP](https://profiles.viictr.org/profile/12583684), Novara G, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Wei C, **Lerner SP** , Curiel TJ, [Kamat AM](https://profiles.viictr.org/profile/12582620), Svatek RS, Fradet Y, Kassouf W, Karakiewicz PI. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology. 2014 Apr; 83(4):863-7. PMID: [24485993](//www.ncbi.nlm.nih.gov/pubmed/24485993).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24485993/citedby/) Fields:

Uro Urology

Translation:Humans

  141. Frazee RC, Elliott VG, Larsen W, **Lerner S** , Minnis KW, Huber C, Nolan J, Papaconstantinou H, Smythe WR. Can laparoscopic cholecystectomy be performed with a positive margin at medicaid reimbursement rates? J Am Coll Surg. 2014 Apr; 218(4):546-51. PMID: [24529812](//www.ncbi.nlm.nih.gov/pubmed/24529812).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24529812/citedby/) Fields:

Gen General SurgeryGyn GynecologyObs Obstetrics

Translation:Humans

  142. Christodouleas JP, Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Tangen CM, **Lerner SP** , Guzzo TJ, Malkowicz SB, Herr H. Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer. 2014 Apr 15; 120(8):1272-80. PMID: [24390799](//www.ncbi.nlm.nih.gov/pubmed/24390799).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24390799/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  143. Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, **Lerner SP** , Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014 Jan; 113(1):11-23. PMID: [24330062](//www.ncbi.nlm.nih.gov/pubmed/24330062).

Citations:
[58](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24330062/citedby/) Fields:

Uro Urology

Translation:Humans

  144. von Rundstedt FC, **Lerner SP**. Bladder cancer: Always consider extravesical sites when BCG fails. Nat Rev Urol. 2014 Jan; 11(1):11-2. PMID: [24346003](//www.ncbi.nlm.nih.gov/pubmed/24346003).

Citations:  Fields:

Uro Urology

Translation:Humans

  145. Jarow JP, **Lerner SP** , Kluetz PG, Liu K, Sridhara R, Bajorin D, Chang S, [Dinney CP](https://profiles.viictr.org/profile/12583684), Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B. Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop. Urology. 2014 Feb; 83(2):262-4. PMID: [24332121](//www.ncbi.nlm.nih.gov/pubmed/24332121).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24332121/citedby/) Fields:

Uro Urology

Translation:Humans

  146. Figueroa JD, [Ye Y](https://profiles.viictr.org/profile/12583090), Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, [Dinney CP](https://profiles.viictr.org/profile/12583684), Baris D, Purdue M, Jacobs EJ, Albanes D, Wang Z, Deng X, Chung CC, Tang W, Bas Bueno-de-Mesquita H, Trichopoulos D, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Brenan P, Chang-Claude J, Riboli E, Conti D, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M, Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner SP** , Barton Grossman H, Lin J, [Gu J](https://profiles.viictr.org/profile/12582970), Pu X, Hutchinson A, Burdette L, Wheeler W, Kogevinas M, Serra C, Carrato A, Lloreta J, Schwenn M, Karagas MR, Johnson A, Schned A, Armenti KR, Hosain GM, Andriole G, Grubb R, Black A, Ryan Diver W, Gapstur SM, Weinstein SJ, Virtamo J, Haiman CA, Landi MT, Caporaso N, Fraumeni JF, Vineis P, [Wu X](https://profiles.viictr.org/profile/12582536), Silverman DT, Chanock S, Rothman N, Malats N, Ljungberg B, Clavel-Chapelon F, Tj?nneland A, Tard?n A, Garc?a-Closas R. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014 Mar 01; 23(5):1387-98. PMID: [24163127](//www.ncbi.nlm.nih.gov/pubmed/24163127); PMCID: [PMC3919005](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3919005).

Citations:
[74](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24163127/citedby/) Fields:

Gen GeneticsMol Molecular Biology

Translation:Humans

  147. George SK, Tovar-Sepulveda V, Shen SS, Jian W, Zhang Y, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), **Lerner SP** , Smith CL. Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Transl Oncol. 2013 Jun; 6(3):244-55. PMID: [23730403](//www.ncbi.nlm.nih.gov/pubmed/23730403); PMCID: [PMC3660792](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3660792).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23730403/citedby/)

  148. Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM, **Lerner SP** , Sagalowsky A, Shariat SF, Bochner BH. Lymphadenectomy for bladder cancer at the time of radical cystectomy. Eur Urol. 2013 Aug; 64(2):266-76. PMID: [23648149](//www.ncbi.nlm.nih.gov/pubmed/23648149).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23648149/citedby/) Fields:

Uro Urology

Translation:Humans

  149. Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz HJ, Lee CT, Wilson SS, Benson M, **Lerner SP** , Tangen CM, Thompson IM. SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Gu?rin. J Urol. 2013 Oct; 190(4):1200-4. PMID: [23597452](//www.ncbi.nlm.nih.gov/pubmed/23597452); PMCID: [PMC4113593](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4113593).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23597452/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  150. Galsky MD, Hendricks R, Svatek R, Bangs R, Hoffman-Censits J, Clement J, Dreicer R, Guancial E, Hahn N, **Lerner SP** , O'Donnell PH, Quale DZ, [Siefker-Radtke A](https://profiles.viictr.org/profile/12582595), Shipley W, Sonpavde G, Vaena D, Vinson J, Rosenberg J. Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group. Cancer. 2013 Jun 01; 119(11):1994-8. PMID: [23456777](//www.ncbi.nlm.nih.gov/pubmed/23456777).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23456777/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  151. Galsky MD, Hahn NM, Powles T, Hellerstedt BA, **Lerner SP** , Gardner TA, Yu M, O'Rourke M, Vogelzang NJ, Kocs D, McKenney SA, Melnyk AM, Hutson TE, Rauch M, Wang Y, Asmar L, Sonpavde G. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clin Genitourin Cancer. 2013 Jun; 11(2):175-81. PMID: [23228446](//www.ncbi.nlm.nih.gov/pubmed/23228446).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23228446/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCTClinical Trials

  152. Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, **Lerner SP** , Sonpavde G, Sagalowsky AI, Gupta A. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. BJU Int. 2013 Jun; 111(8):1215-21. PMID: [23181623](//www.ncbi.nlm.nih.gov/pubmed/23181623).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23181623/citedby/) Fields:

Uro Urology

Translation:Humans

  153. Burke JM, Lamm DL, Meng MV, Nemunaitis JJ, Stephenson JJ, Arseneau JC, Aimi J, **Lerner S** , Yeung AW, Kazarian T, Maslyar DJ, McKiernan JM. A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. J Urol. 2012 Dec; 188(6):2391-7. PMID: [23088985](//www.ncbi.nlm.nih.gov/pubmed/23088985).

Citations:
[80](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23088985/citedby/) Fields:

Uro Urology

Translation:HumansCellsCTClinical Trials

  154. Stamatakis L, [Godoy G](https://profiles.viictr.org/profile/267612), **Lerner SP**. Innovations in radical cystectomy and pelvic lymph node dissection. Semin Oncol. 2012 Oct; 39(5):573-82. PMID: [23040253](//www.ncbi.nlm.nih.gov/pubmed/23040253).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23040253/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  155. Hoffman KL, **Lerner SP** , [Smith CL](https://profiles.viictr.org/profile/266576). Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation. Horm Cancer. 2013 Feb; 4(1):24-35. PMID: [22965848](//www.ncbi.nlm.nih.gov/pubmed/22965848); PMCID: [PMC3541450](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3541450).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22965848/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:HumansCells

  156. Ku JH, **Lerner SP**. Strategies to prevent progression of high-risk bladder cancer at initial diagnosis. Curr Opin Urol. 2012 Sep; 22(5):405-14. PMID: [22842680](//www.ncbi.nlm.nih.gov/pubmed/22842680).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22842680/citedby/) Fields:

Uro Urology

Translation:Humans

  157. Droller MJ, ad hoc Committee on Plagiarism, Bahnson RR, **Lerner SP** , Schoenberg M, Thalmann GA. Plagiarism. Urol Oncol. 2012 Sep; 30(5):547-8. PMID: [23021554](//www.ncbi.nlm.nih.gov/pubmed/23021554).

Citations:  Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  158. Gakis G, Efstathiou J, **Lerner SP** , Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladd. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan; 63(1):45-57. PMID: [22917985](//www.ncbi.nlm.nih.gov/pubmed/22917985).

Citations:
[125](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22917985/citedby/)
Fields:

Uro Urology

Translation:Humans

  159. Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, **Lerner SP** , Mason M, Powles T, Sternberg CN, Sonpavde G. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2012 Sep; 62(3):523-33. PMID: [22677572](//www.ncbi.nlm.nih.gov/pubmed/22677572).

Citations:
[87](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22677572/citedby/) Fields:

Uro Urology

Translation:Humans

  160. Alva AS, [Matin SF](https://profiles.viictr.org/profile/12583401), **Lerner SP** , [Siefker-Radtke AO](https://profiles.viictr.org/profile/12582595). Perioperative chemotherapy for upper tract urothelial cancer. Nat Rev Urol. 2012 Apr 10; 9(5):266-73. PMID: [22487872](//www.ncbi.nlm.nih.gov/pubmed/22487872).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22487872/citedby/) Fields:

Uro Urology

Translation:Humans

  161. Jian PY, [Godoy G](https://profiles.viictr.org/profile/267612), [Coburn M](https://profiles.viictr.org/profile/266826), [Lynch G](https://profiles.viictr.org/profile/269644), Ro JY, Zhai QJ, Nishino M, **Lerner SP**. Adenocarcinoma following urinary diversion. Can Urol Assoc J. 2012 Apr; 6(2):E77-80. PMID: [22511440](//www.ncbi.nlm.nih.gov/pubmed/22511440); PMCID: [PMC3328579](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3328579).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22511440/citedby/)

  162. Ku JH, [Godoy G](https://profiles.viictr.org/profile/267612), Amiel GE, **Lerner SP**. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review. BJU Int. 2012 Sep; 110(5):630-6. PMID: [22353238](//www.ncbi.nlm.nih.gov/pubmed/22353238).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22353238/citedby/) Fields:

Uro Urology

Translation:Humans

  163. Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, [Godoy G](https://profiles.viictr.org/profile/267612), **Lerner SP** , van de Rijn M, Shortliffe LD, Weissman IL, [Chan KS](https://profiles.viictr.org/profile/266205). Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A. 2012 Feb 07; 109(6):2078-83. PMID: [22308455](//www.ncbi.nlm.nih.gov/pubmed/22308455); PMCID: [PMC3277552](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3277552).

Citations:
[122](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22308455/citedby/)
Fields:

Sci Science

Translation:HumansCells

  164. Hosain GM, Khan MM, Amiel GE, **Lerner SP** , [Latini DM](https://profiles.viictr.org/profile/265641), Chen GJ. Racial/ethnic differences in upper-tract urothelial cancer. Ethn Dis. 2012; 22(3):295-301. PMID: [22870572](//www.ncbi.nlm.nih.gov/pubmed/22870572).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22870572/citedby/) Fields:

Pub Public HealthSoc Social Sciences

Translation:Humans

  165. Ku JH, **Lerner SP**. Variables affecting long-term maintenance of renal function following ileal based urinary diversion. Eur Urol. 2012 Mar; 61(3):498-500; discussion 500-2. PMID: [22206798](//www.ncbi.nlm.nih.gov/pubmed/22206798).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22206798/citedby/) Fields:

Uro Urology

Translation:Humans

  166. **Lerner SP** , Kibel AS. Highlights of the 2010 SUO Annual Meeting. Urol Oncol. 2011 Nov-Dec; 29(6):825. PMID: [22078405](//www.ncbi.nlm.nih.gov/pubmed/22078405).

Citations:  Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  167. [Sabichi AL](https://profiles.viictr.org/profile/269948), [Lee JJ](https://profiles.viictr.org/profile/12583680), Grossman HB, [Liu S](https://profiles.viictr.org/profile/12583848), Richmond E, [Czerniak BA](https://profiles.viictr.org/profile/12582882), De la Cerda J, Eagle C, Viner JL, Palmer JL, **Lerner SP**. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1580-9. PMID: [21881030](//www.ncbi.nlm.nih.gov/pubmed/21881030); PMCID: [PMC4028708](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4028708).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21881030/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  168. Garcia-Closas M, [Ye Y](https://profiles.viictr.org/profile/12583090), Rothman N, Figueroa JD, [Dinney CP](https://profiles.viictr.org/profile/12583684), Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, [Kamat AM](https://profiles.viictr.org/profile/12582620), **Lerner SP** , Grossman HB, [Gu J](https://profiles.viictr.org/profile/12582970), Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Serra C, Carrato A, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni JF, Silverman DT, Chanock SJ, [Wu X](https://profiles.viictr.org/profile/12582536), Malats N, Tard?n A, Garc?a-Closas R. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet. 2011 Nov 01; 20(21):4282-9. PMID: [21824976](//www.ncbi.nlm.nih.gov/pubmed/21824976); PMCID: [PMC3188994](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3188994).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21824976/citedby/) Fields:

Gen GeneticsMol Molecular Biology

Translation:HumansCells

  169. Stadler WM, **Lerner SP** , Groshen S, Stein JP, Shi SR, Raghavan D, Esrig D, Steinberg G, Wood D, Klotz L, Hall C, Skinner DG, Cote RJ. Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol. 2011 Sep 01; 29(25):3443-9. PMID: [21810677](//www.ncbi.nlm.nih.gov/pubmed/21810677); PMCID: [PMC3164246](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3164246).

Citations:
[75](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21810677/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  170. Swanson GP, **Lerner SP**. Positive margins after radical prostatectomy: implications for failure and role of adjuvant treatment. Urol Oncol. 2013 Jul; 31(5):531-41. PMID: [21775170](//www.ncbi.nlm.nih.gov/pubmed/21775170).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21775170/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  171. Levitt JM, Jian W, **Lerner SP** , Sonpavde G. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma. Urol Oncol. 2013 Feb; 31(2):234-40. PMID: [21723160](//www.ncbi.nlm.nih.gov/pubmed/21723160).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21723160/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansAnimalsCells

  172. Svatek RS, Shariat SF, Novara G, **Lerner SP** , Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, [Dinney CP](https://profiles.viictr.org/profile/12583684), Tilki D, [Kamat AM](https://profiles.viictr.org/profile/12582620), Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC, Kassouf W. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. 2013 May; 31(4):480-6. PMID: [21478035](//www.ncbi.nlm.nih.gov/pubmed/21478035).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21478035/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  173. **Lerner SP** , [Liu H](https://profiles.viictr.org/profile/265543), Wu MF, Thomas YK, Witjes JA. Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder. Urol Oncol. 2012 May-Jun; 30(3):285-9. PMID: [21396840](//www.ncbi.nlm.nih.gov/pubmed/21396840).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21396840/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  174. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, **Lerner SP** , Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, [Dinney CP](https://profiles.viictr.org/profile/12583684), Lotan Y, Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. J Urol. 2011 Apr; 185(4):1216-21. PMID: [21334687](//www.ncbi.nlm.nih.gov/pubmed/21334687).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21334687/citedby/) Fields:

Uro Urology

Translation:Humans

  175. Sonpavde G, Khan MM, **Lerner SP** , Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, [Dinney CP](https://profiles.viictr.org/profile/12583684), Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF. Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol. 2011 Feb; 185(2):456-61. PMID: [21167527](//www.ncbi.nlm.nih.gov/pubmed/21167527).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21167527/citedby/) Fields:

Uro Urology

Translation:Humans

  176. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, **Lerner SP** , Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, [Dinney CP](https://profiles.viictr.org/profile/12583684), Lotan Y, Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU Int. 2011 Sep; 108(5):687-92. PMID: [21087453](//www.ncbi.nlm.nih.gov/pubmed/21087453).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21087453/citedby/) Fields:

Uro Urology

Translation:Humans

  177. **Lerner SP**. Editorial comment. Urology. 2010 Oct; 76(4):913-4. PMID: [20932409](//www.ncbi.nlm.nih.gov/pubmed/20932409).

Citations:  Fields:

Uro Urology

  178. **Lerner SP**. Editorial comment. Urology. 2010 Sep; 76(3):603; discussion 603-4. PMID: [20832607](//www.ncbi.nlm.nih.gov/pubmed/20832607).

Citations:  Fields:

Uro Urology

  179. Tilki D, Svatek RS, Novara G, Seitz M, [Godoy G](https://profiles.viictr.org/profile/267612), Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, **Lerner SP** , Schoenberg M, Stief CG, [Dinney CP](https://profiles.viictr.org/profile/12583684), Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol. 2010 Sep; 184(3):888-94. PMID: [20643448](//www.ncbi.nlm.nih.gov/pubmed/20643448).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20643448/citedby/) Fields:

Uro Urology

Translation:Humans

  180. Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, **Lerner SP** , Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, [Siefker-Radtke AO](https://profiles.viictr.org/profile/12582595), Millikan RE, [Dinney CP](https://profiles.viictr.org/profile/12583684), M?ller SC. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res. 2010 Sep 01; 16(17):4461-7. PMID: [20651056](//www.ncbi.nlm.nih.gov/pubmed/20651056).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20651056/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  181. **Lerner SP**. Editorial comment. J Urol. 2010 Jul; 184(1):79-80. PMID: [20546804](//www.ncbi.nlm.nih.gov/pubmed/20546804).

Citations:  Fields:

Uro Urology

Translation:Humans

  182. Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, [Dinney CP](https://profiles.viictr.org/profile/12583684), **Lerner SP** , Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010 Jun; 183(6):2165-70. PMID: [20399473](//www.ncbi.nlm.nih.gov/pubmed/20399473).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20399473/citedby/) Fields:

Uro Urology

Translation:Humans

  183. Kassouf W, Hautmann RE, Bochner BH, **Lerner SP** , Colombo R, Zlotta A, Studer UE. A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution? Eur Urol. 2010 Sep; 58(3):374-83. PMID: [20605317](//www.ncbi.nlm.nih.gov/pubmed/20605317).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20605317/citedby/) Fields:

Uro Urology

Translation:Humans

  184. **Lerner SP** , Grossman HB, Messing EM, Kibel AS, Stephenson A, Gee JR, O'Donnell MA, Reid RD, [Kamat AM](https://profiles.viictr.org/profile/12582620), Parnes HL, House MG. BCAN Think Tank session 3: Prevention of bladder cancer. Urol Oncol. 2010 May-Jun; 28(3):338-42. PMID: [20439034](//www.ncbi.nlm.nih.gov/pubmed/20439034).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20439034/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  185. Levitt JM, Yamashita H, Jian W, **Lerner SP** , Sonpavde G. Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling. Mol Cancer Ther. 2010 May; 9(5):1128-35. PMID: [20406945](//www.ncbi.nlm.nih.gov/pubmed/20406945).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20406945/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansAnimalsCells

  186. Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, **Lerner SP** , Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF, Tilki D. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol. 2010 May; 183(5):1757-63. PMID: [20299059](//www.ncbi.nlm.nih.gov/pubmed/20299059).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20299059/citedby/) Fields:

Uro Urology

Translation:Humans

  187. Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, **Lerner SP** , Louhimo J, Sawczuk I, Taketa K, Diamandis EP, National Academy of Clinical Biochemistry, L?he F. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem. 2010 Jun; 56(6):e1-48. PMID: [20207771](//www.ncbi.nlm.nih.gov/pubmed/20207771).

Citations:
[64](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20207771/citedby/) Fields:

Che Chemistry

Translation:Humans

  188. Lawrentschuk N, Colombo R, Hakenberg OW, **Lerner SP** , Sagalowsky A, Wirth MP, M?nsson W. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol. 2010 Jun; 57(6):983-1001. PMID: [20227172](//www.ncbi.nlm.nih.gov/pubmed/20227172).

Citations:
[59](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20227172/citedby/) Fields:

Uro Urology

Translation:Humans

  189. Rabbani F, Lee C, Chang SS, **Lerner SP** , Wood DP, Herr HW. Accuracy of the extent of bladder cancer nodal metastases found at pelvic lymphadenectomy at the time of cystectomy: relation to primary tumor stage. Urol Int. 2010; 84(1):14-22. PMID: [20173363](//www.ncbi.nlm.nih.gov/pubmed/20173363).

Citations:  Fields:

Uro Urology

Translation:Humans

  190. Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, **Lerner SP** , Sagalowsky AI, Schoenberg MP, [Kamat AM](https://profiles.viictr.org/profile/12582620), [Dinney CP](https://profiles.viictr.org/profile/12583684), Lotan Y, Marberger MJ, Fradet Y. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int. 2010 May; 105(10):1402-12. PMID: [20132195](//www.ncbi.nlm.nih.gov/pubmed/20132195).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20132195/citedby/) Fields:

Uro Urology

Translation:Humans

  191. Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, **Lerner SP** , Sagalowsky AI, Cote RJ, Lotan Y. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol. 2010 Jan; 183(1):68-75. PMID: [19913255](//www.ncbi.nlm.nih.gov/pubmed/19913255).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19913255/citedby/) Fields:

Uro Urology

Translation:Humans

  192. Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, **Lerner SP** , Schoenberg M, [Dinney CP](https://profiles.viictr.org/profile/12583684), Skinner E, Lotan Y, Sagalowsky AI, Shariat SF, Tilki D. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol. 2010 Jan; 183(1):87-93. PMID: [19942232](//www.ncbi.nlm.nih.gov/pubmed/19942232).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19942232/citedby/) Fields:

Uro Urology

Translation:Humans

  193. **Lerner SP** , Bochner B, Linehan WM, Klein E, Cookson M. Overview of SUO Winter 2008 proceedings. Urol Oncol. 2010 Jan-Feb; 28(1):67-8. PMID: [20123350](//www.ncbi.nlm.nih.gov/pubmed/20123350).

Citations:  Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  194. **Lerner SP**. Editorial comment. J Urol. 2010 Feb; 183(2):504. PMID: [20006886](//www.ncbi.nlm.nih.gov/pubmed/20006886).

Citations:  Fields:

Uro Urology

Translation:Humans

  195. [Latini DM](https://profiles.viictr.org/profile/265641), **Lerner SP** , Wade SW, Lee DW, Quale DZ. Bladder cancer detection, treatment and outcomes: opportunities and challenges. Urology. 2010 Feb; 75(2):334-9. PMID: [19963252](//www.ncbi.nlm.nih.gov/pubmed/19963252).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19963252/citedby/) Fields:

Uro Urology

Translation:Humans

  196. Sonpavde G, Goldman BH, Speights VO, **Lerner SP** , Wood DP, Vogelzang NJ, Trump DL, Natale RB, Grossman HB, Crawford ED. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer. 2009 Sep 15; 115(18):4104-9. PMID: [19517476](//www.ncbi.nlm.nih.gov/pubmed/19517476); PMCID: [PMC3079554](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3079554).

Citations:
[53](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19517476/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  197. Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, **Lerner S** , Sagalowsky AI, Schoenberg M, [Kamat A](https://profiles.viictr.org/profile/12582620), [Dinney CP](https://profiles.viictr.org/profile/12583684), Lotan Y, Shariat SF. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol. 2010 Feb; 57(2):300-9. PMID: [19766384](//www.ncbi.nlm.nih.gov/pubmed/19766384).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19766384/citedby/) Fields:

Uro Urology

Translation:Humans

  198. **Lerner SP**. Innovations in endoscopic imaging for bladder cancer. Eur Urol. 2009 Dec; 56(6):920-2. PMID: [19665285](//www.ncbi.nlm.nih.gov/pubmed/19665285).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19665285/citedby/) Fields:

Uro Urology

Translation:Humans

  199. Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, **Lerner SP** , Montorsi F, Sagalowsky AI, Cote RJ, Lotan Y, Rigaud J, M?ller SC. p53 expression in patients with advanced urothelial cancer of the urinary bladder. BJU Int. 2010 Feb; 105(4):489-95. PMID: [19659466](//www.ncbi.nlm.nih.gov/pubmed/19659466).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19659466/citedby/) Fields:

Uro Urology

Translation:Humans

  200. Shariat SF, Lotan Y, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, [Karam JA](https://profiles.viictr.org/profile/12583922), Heukamp LC, Netto G, **Lerner SP** , Sagalowsky AI, Cote RJ, M?ller SC. p53 predictive value for pT1-2 N0 disease at radical cystectomy. J Urol. 2009 Sep; 182(3):907-13. PMID: [19616250](//www.ncbi.nlm.nih.gov/pubmed/19616250).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19616250/citedby/) Fields:

Uro Urology

Translation:Humans

  201. **Lerner SP**. The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma. Curr Treat Options Oncol. 2009 Aug; 10(3-4):267-74. PMID: [19565335](//www.ncbi.nlm.nih.gov/pubmed/19565335).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19565335/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  202. Karakiewicz PI, Shariat SF, Capitanio U, Palapattu GS, Sagalowsky AI, Lotan Y, Schoenberg MP, Amiel GE, **Lerner SP** , Sonpavde G, Isbarn H. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. J Urol. 2009 Aug; 182(2):459-65; discussion 465. PMID: [19524971](//www.ncbi.nlm.nih.gov/pubmed/19524971).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19524971/citedby/) Fields:

Uro Urology

Translation:Humans

  203. Jian W, Yamashita H, Levitt JM, **Lerner SP** , Sonpavde G. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Mol Cancer Ther. 2009 Jul; 8(7):1772-8. PMID: [19509273](//www.ncbi.nlm.nih.gov/pubmed/19509273).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19509273/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansAnimalsCells

  204. del Pozo AC, Rodriguez-Laiz G, Sturdevant M, Iyer K, Schwartz M, Schiano T, **Lerner S** , Ames S, Bromberg J, Thung S, de Boccardo G, Mart?n JD. Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience. Transplant Proc. 2009 Jun; 41(5):1713-6. PMID: [19545713](//www.ncbi.nlm.nih.gov/pubmed/19545713).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19545713/citedby/) Fields:

Tra Transplantation

Translation:Humans

  205. Shariat SF, Karakiewicz PI, [Godoy G](https://profiles.viictr.org/profile/267612), **Lerner SP**. Use of nomograms for predictions of outcome in patients with advanced bladder cancer. Ther Adv Urol. 2009 Apr; 1(1):13-26. PMID: [21789050](//www.ncbi.nlm.nih.gov/pubmed/21789050); PMCID: [PMC3126044](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3126044).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21789050/citedby/)

  206. Goh AC, **Lerner SP**. Application of new technology in bladder cancer diagnosis and treatment. World J Urol. 2009 Jun; 27(3):301-7. PMID: [19234856](//www.ncbi.nlm.nih.gov/pubmed/19234856).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19234856/citedby/) Fields:

Uro Urology

Translation:Humans

  207. Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, Capitanio U, Montorsi F, Bastian PJ, Nielsen ME, Heukamp LC, Netto G, **Lerner SP** , Sagalowsky AI, Shariat SF, M?ller SC, Rigaud J. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst. 2009 Jan 21; 101(2):114-9. PMID: [19141773](//www.ncbi.nlm.nih.gov/pubmed/19141773).

Citations:
[43](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19141773/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  208. Capitanio U, Suardi N, Shariat SF, Lotan Y, Palapattu GS, Bastian PJ, Gupta A, Vazina A, Schoenberg M, **Lerner SP** , Sagalowsky AI, Karakiewicz PI. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int. 2009 May; 103(10):1359-62. PMID: [19076140](//www.ncbi.nlm.nih.gov/pubmed/19076140).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19076140/citedby/) Fields:

Uro Urology

Translation:Humans

  209. Sternberg CN, **Lerner SP** , Fitzpatrick JM. Bladder cancer today. BJU Int. 2008 Nov; 102(9 Pt B):1203. PMID: [19035882](//www.ncbi.nlm.nih.gov/pubmed/19035882).

Citations:  Fields:

Uro Urology

Translation:Humans

  210. **Lerner SP** , Au JL. Risk-adapted use of intravesical chemotherapy. BJU Int. 2008 Nov; 102(9 Pt B):1247-53. PMID: [19035889](//www.ncbi.nlm.nih.gov/pubmed/19035889).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19035889/citedby/) Fields:

Uro Urology

Translation:Humans

  211. **Lerner SP** , Colen J, Shen S. Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma. Curr Opin Urol. 2008 Sep; 18(5):508-12. PMID: [18670276](//www.ncbi.nlm.nih.gov/pubmed/18670276).

Citations:  Fields:

Uro Urology

Translation:Humans

  212. Delclos GL, **Lerner SP**. Occupational risk factors. Scand J Urol Nephrol Suppl. 2008 Sep; (218):58-63. PMID: [18815918](//www.ncbi.nlm.nih.gov/pubmed/18815918).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18815918/citedby/) Fields:

Nep NephrologyUro Urology

Translation:HumansPHPublic Health

  213. **Lerner SP** , Shen S. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer. Urol Oncol. 2008 Sep-Oct; 26(5):481-5. PMID: [18774459](//www.ncbi.nlm.nih.gov/pubmed/18774459).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18774459/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  214. Sonpavde G, Amiel GE, Mims MP, Hayes TG, **Lerner SP**. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer. Expert Opin Pharmacother. 2008 Aug; 9(11):1885-93. PMID: [18627327](//www.ncbi.nlm.nih.gov/pubmed/18627327).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18627327/citedby/) Fields:

Pha Pharmacology

Translation:Humans

  215. Goh AC, Tresser NJ, Shen SS, **Lerner SP**. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology. 2008 Jul; 72(1):133-7. PMID: [18598789](//www.ncbi.nlm.nih.gov/pubmed/18598789).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18598789/citedby/) Fields:

Uro Urology

Translation:Humans

  216. Sonpavde G, Jian W, [Liu H](https://profiles.viictr.org/profile/265543), Wu MF, Shen SS, **Lerner SP**. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. Urol Oncol. 2009 Jul-Aug; 27(4):391-9. PMID: [18534874](//www.ncbi.nlm.nih.gov/pubmed/18534874).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18534874/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansAnimalsCells

  217. Walz J, Shariat SF, Suardi N, Perrotte P, Lotan Y, Palapattu GS, Gupta A, Bastian PJ, Rogers CG, Vazina A, Amiel GE, Sagalowsky AI, Schoenberg M, **Lerner SP** , Karakiewicz PI. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study. BJU Int. 2008 Jun; 101(11):1356-61. PMID: [18454792](//www.ncbi.nlm.nih.gov/pubmed/18454792).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18454792/citedby/) Fields:

Uro Urology

Translation:Humans

  218. Hendricksen K, Gleason D, Young JM, Saltzstein D, Gershman A, **Lerner S** , Witjes JA. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer. J Urol. 2008 Jul; 180(1):116-20. PMID: [18485407](//www.ncbi.nlm.nih.gov/pubmed/18485407).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18485407/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  219. **Lerner SP** , Tangen CM, Sucharew H, Wood D, Crawford ED. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol. 2009 Mar-Apr; 27(2):155-9. PMID: [18367117](//www.ncbi.nlm.nih.gov/pubmed/18367117); PMCID: [PMC2695968](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2695968).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18367117/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  220. Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, **Lerner SP** , Sagalowsky AI, Shariat SF, Bladder Cancer Research Consortium. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology. 2008 Feb; 71(2):302-7. PMID: [18308108](//www.ncbi.nlm.nih.gov/pubmed/18308108).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18308108/citedby/) Fields:

Uro Urology

Translation:Humans

  221. Bellows CF, Jian W, McHale MK, Cardenas D, West JL, **Lerner SP** , Amiel GE. Blood vessel matrix: a new alternative for abdominal wall reconstruction. Hernia. 2008 Aug; 12(4):351-8. PMID: [18235999](//www.ncbi.nlm.nih.gov/pubmed/18235999).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18235999/citedby/) Fields:

Gas GastroenterologyGen General Surgery

Translation:Animals

  222. Shariat SF, Karakiewicz PI, Ashfaq R, **Lerner SP** , Palapattu GS, Cote RJ, Sagalowsky AI, Lotan Y. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer. 2008 Jan 15; 112(2):315-25. PMID: [18008359](//www.ncbi.nlm.nih.gov/pubmed/18008359).

Citations:
[49](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18008359/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  223. [Sabichi AL](https://profiles.viictr.org/profile/269948), **Lerner SP** , Atkinson EN, Grossman HB, [Caraway NP](https://profiles.viictr.org/profile/12582519), [Dinney CP](https://profiles.viictr.org/profile/12583684), Penson DF, [Matin S](https://profiles.viictr.org/profile/12583401), [Kamat A](https://profiles.viictr.org/profile/12582620), [Pisters LL](https://profiles.viictr.org/profile/12582535), Lin DW, [Katz RL](https://profiles.viictr.org/profile/12582502), Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9. PMID: [18172274](//www.ncbi.nlm.nih.gov/pubmed/18172274).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18172274/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  224. Shariat SF, [Karam JA](https://profiles.viictr.org/profile/12583922), **Lerner SP**. Molecular markers in bladder cancer. Curr Opin Urol. 2008 Jan; 18(1):1-8. PMID: [18090481](//www.ncbi.nlm.nih.gov/pubmed/18090481).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18090481/citedby/) Fields:

Uro Urology

Translation:Humans

  225. Sonpavde G, **Lerner SP**. Neoadjuvant chemotherapy for bladder cancer. Oncology (Williston Park). 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PMID: [18247016](//www.ncbi.nlm.nih.gov/pubmed/18247016).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18247016/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  226. **Lerner SP**. Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol. 2007 Dec; 52(6):1708-9. PMID: [17646045](//www.ncbi.nlm.nih.gov/pubmed/17646045).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17646045/citedby/) Fields:

Uro Urology

Translation:Animals

  227. Sonpavde G, Ross R, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, **Lerner SP** , Sternberg CN. Novel agents for muscle-invasive and advanced urothelial cancer. BJU Int. 2008 Apr; 101(8):937-43. PMID: [18005203](//www.ncbi.nlm.nih.gov/pubmed/18005203).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18005203/citedby/) Fields:

Uro Urology

Translation:Humans

  228. Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, **Lerner SP** , Schoenberg MP, Karakiewicz PI, Bladder Cancer Research Consortium. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int. 2008 Feb; 101(4):450-4. PMID: [17850359](//www.ncbi.nlm.nih.gov/pubmed/17850359).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17850359/citedby/) Fields:

Uro Urology

Translation:Humans

  229. Nielsen ME, Palapattu GS, Karakiewicz PI, Lotan Y, Bastian PJ, **Lerner SP** , Sagalowsky AI, Schoenberg MP, Shariat SF. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int. 2007 Nov; 100(5):1015-20. PMID: [17784888](//www.ncbi.nlm.nih.gov/pubmed/17784888).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17784888/citedby/) Fields:

Uro Urology

Translation:Humans

  230. Chen M, [Kamat AM](https://profiles.viictr.org/profile/12582620), Huang M, Grossman HB, [Dinney CP](https://profiles.viictr.org/profile/12583684), **Lerner SP** , [Wu X](https://profiles.viictr.org/profile/12582536), [Gu J](https://profiles.viictr.org/profile/12582970). High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis. 2007 Oct; 28(10):2160-5. PMID: [17728339](//www.ncbi.nlm.nih.gov/pubmed/17728339).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17728339/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  231. Shen SS, **Lerner SP**. Prostatic transitional cell carcinoma: pathologic features and clinical management. Expert Rev Anticancer Ther. 2007 Aug; 7(8):1155-62. PMID: [18028024](//www.ncbi.nlm.nih.gov/pubmed/18028024).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18028024/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  232. **Lerner SP** , Bochner B, Kibel AS. The use and abuse of data: nomograms and talking to patients about clinical medicine. Urol Oncol. 2007 Jul-Aug; 25(4):333-7. PMID: [17628303](//www.ncbi.nlm.nih.gov/pubmed/17628303).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17628303/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  233. Sonpavde G, Okuno N, Weiss H, Yu J, Shen SS, Younes M, Jian W, **Lerner SP** , [Smith CL](https://profiles.viictr.org/profile/266576). Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology. 2007 Jun; 69(6):1221-6. PMID: [17572228](//www.ncbi.nlm.nih.gov/pubmed/17572228).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17572228/citedby/) Fields:

Uro Urology

Translation:HumansAnimalsCells

  234. Grossman HB, Gomella L, **Lerner S** , Cookson M, Albala D, Droller MJ, PC B302/01 Study Group, Fradet Y. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007 Jul; 178(1):68-73; discussion 73. PMID: [17499291](//www.ncbi.nlm.nih.gov/pubmed/17499291).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17499291/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  235. **Lerner SP** , Tangen CM, Sucharew H, Wood D, Crawford ED. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer. J Urol. 2007 May; 177(5):1727-31. PMID: [17437798](//www.ncbi.nlm.nih.gov/pubmed/17437798).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17437798/citedby/) Fields:

Uro Urology

Translation:Humans

  236. Baniel J, Klotz L, Wood D, Cookson M, **Lerner S** , Horie S, Schoenberg M, Angulo J, Bassi P, Palou J. Urothelial carcinoma of the prostate. Urology. 2007 Jan; 69(1 Suppl):50-61. PMID: [17280908](//www.ncbi.nlm.nih.gov/pubmed/17280908).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17280908/citedby/) Fields:

Uro Urology

Translation:Humans

  237. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, **Lerner SP**. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PMID: [17085118](//www.ncbi.nlm.nih.gov/pubmed/17085118).

Citations:
[177](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17085118/citedby/)
Fields:

Uro Urology

Translation:Humans

  238. Shariat SF, Karakiewicz PI, Palapattu GS, Amiel GE, Lotan Y, Rogers CG, Vazina A, Bastian PJ, Gupta A, Sagalowsky AI, Schoenberg M, **Lerner SP**. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006 Nov 15; 12(22):6663-76. PMID: [17121885](//www.ncbi.nlm.nih.gov/pubmed/17121885).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17121885/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  239. Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, **Lerner SP** , Sagalowsky AI, Schoenberg MP, Palapattu GS, Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007 Mar; 51(3):699-706; discussion 706-8. PMID: [17113703](//www.ncbi.nlm.nih.gov/pubmed/17113703).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17113703/citedby/) Fields:

Uro Urology

Translation:Humans

  240. Golijanin DJ, Kakiashvili D, Madeb RR, Messing EM, **Lerner SP**. Chemoprevention of bladder cancer. World J Urol. 2006 Nov; 24(5):445-72. PMID: [17048030](//www.ncbi.nlm.nih.gov/pubmed/17048030).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17048030/citedby/) Fields:

Uro Urology

Translation:Humans

  241. Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, **Lerner SP**. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PMID: [16952631](//www.ncbi.nlm.nih.gov/pubmed/16952631).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16952631/citedby/) Fields:

Uro Urology

Translation:Humans

  242. Shariat SF, Palapattu GS, Amiel GE, Karakiewicz PI, Rogers CG, Vazina A, Schoenberg MP, **Lerner SP** , Sagalowsky AI, Lotan Y. Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology. 2006 Sep; 68(3):538-42. PMID: [16979748](//www.ncbi.nlm.nih.gov/pubmed/16979748).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16979748/citedby/) Fields:

Uro Urology

Translation:Humans

  243. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, **Lerner SP** , Sagalowsky AI, Lotan Y. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol. 2007 Jan; 51(1):152-60. PMID: [17011114](//www.ncbi.nlm.nih.gov/pubmed/17011114).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17011114/citedby/) Fields:

Uro Urology

Translation:Humans

  244. Tahir SA, Frolov A, Hayes TG, Mims MP, [Miles BJ](https://profiles.viictr.org/profile/268161), **Lerner SP** , [Wheeler TM](https://profiles.viictr.org/profile/266558), Ayala G, [Thompson TC](https://profiles.viictr.org/profile/12582753), [Kadmon D](https://profiles.viictr.org/profile/268024). Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15; 12(16):4872-5. PMID: [16914574](//www.ncbi.nlm.nih.gov/pubmed/16914574).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16914574/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  245. **Lerner SP**. Treatment of high-risk, non-muscle-invasive bladder cancer. Nat Clin Pract Urol. 2006 Aug; 3(8):398-9. PMID: [16902498](//www.ncbi.nlm.nih.gov/pubmed/16902498).

Citations:  Fields:

Uro Urology

Translation:Humans

  246. **Lerner SP**. Advances in diagnosis and therapy of transitional cell carcinoma of the bladder. Urol Oncol. 2006 Jul-Aug; 24(4):324-5. PMID: [16818186](//www.ncbi.nlm.nih.gov/pubmed/16818186).

Citations:  Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  247. Karakiewicz PI, Shariat SF, Palapattu GS, Perrotte P, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg M, **Lerner SP**. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol. 2006 Dec; 50(6):1254-60; discussion 1261-2. PMID: [16831511](//www.ncbi.nlm.nih.gov/pubmed/16831511).

Citations:
[46](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16831511/citedby/) Fields:

Uro Urology

Translation:Humans

  248. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, **Lerner SP**. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer. 2006 Jun 15; 106(12):2610-6. PMID: [16700038](//www.ncbi.nlm.nih.gov/pubmed/16700038).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16700038/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  249. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, **Lerner SP** , Sagalowsky AI, Lotan Y. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol. 2007 Jan; 51(1):137-49; discussion 149-51. PMID: [16793197](//www.ncbi.nlm.nih.gov/pubmed/16793197).

Citations:
[85](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16793197/citedby/) Fields:

Uro Urology

Translation:Humans

  250. Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, **Lerner SP** , Schoenberg MP. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol. 2006 Jun; 175(6):2048-53; discussion 2053. PMID: [16697800](//www.ncbi.nlm.nih.gov/pubmed/16697800).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16697800/citedby/) Fields:

Uro Urology

Translation:Humans

  251. Shen SS, **Lerner SP** , Muezzinoglu B, [Truong LD](https://profiles.viictr.org/profile/267800), Amiel G, [Wheeler TM](https://profiles.viictr.org/profile/266558). Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol. 2006 Jun; 37(6):726-34. PMID: [16733214](//www.ncbi.nlm.nih.gov/pubmed/16733214).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16733214/citedby/) Fields:

Pat Pathology

Translation:Humans

  252. Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, **Lerner SP** , Schoenberg MP, Bladder Cancer Research Consortium. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol. 2006 May; 175(5):1645-9; discussion 1649. PMID: [16600721](//www.ncbi.nlm.nih.gov/pubmed/16600721).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16600721/citedby/) Fields:

Uro Urology

Translation:Humans

  253. [Sabichi AL](https://profiles.viictr.org/profile/269948), [Lee JJ](https://profiles.viictr.org/profile/12583680), Taylor RJ, Thompson IM, [Miles BJ](https://profiles.viictr.org/profile/268161), Tangen CM, Minasian LM, [Pisters LL](https://profiles.viictr.org/profile/12582535), Caton JR, Basler JW, **Lerner SP** , [Menter DG](https://profiles.viictr.org/profile/12583645), Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. PMID: [16609032](//www.ncbi.nlm.nih.gov/pubmed/16609032).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16609032/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  254. Amiel GE, **Lerner SP**. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions. Expert Rev Anticancer Ther. 2006 Feb; 6(2):281-91. PMID: [16445380](//www.ncbi.nlm.nih.gov/pubmed/16445380).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16445380/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  255. [Wu X](https://profiles.viictr.org/profile/12582536), [Gu J](https://profiles.viictr.org/profile/12582970), Grossman HB, [Amos CI](https://profiles.viictr.org/profile/23372697), Etzel C, Huang M, Zhang Q, Millikan RE, **Lerner S** , [Dinney CP](https://profiles.viictr.org/profile/12583684), [Spitz MR](https://profiles.viictr.org/profile/266382). Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79. PMID: [16465622](//www.ncbi.nlm.nih.gov/pubmed/16465622); PMCID: [PMC1380289](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1380289).

Citations:
[124](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16465622/citedby/)
Fields:

Gen Genetics

Translation:HumansCells

  256. Motta M, Rassenti L, Shelvin BJ, **Lerner S** , Kipps TJ, Keating MJ, [Wierda WG](https://profiles.viictr.org/profile/12582613). Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia. Leukemia. 2005 Oct; 19(10):1788-93. PMID: [16094420](//www.ncbi.nlm.nih.gov/pubmed/16094420).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16094420/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  257. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, **Lerner SP** , Sagalowsky AI. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005 Sep 20; 23(27):6533-9. PMID: [16116151](//www.ncbi.nlm.nih.gov/pubmed/16116151).

Citations:
[69](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16116151/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  258. Leibovici D, Grossman HB, [Dinney CP](https://profiles.viictr.org/profile/12583684), Millikan RE, **Lerner S** , Wang Y, [Gu J](https://profiles.viictr.org/profile/12582970), Dong Q, [Wu X](https://profiles.viictr.org/profile/12582536). Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol. 2005 Aug 20; 23(24):5746-56. PMID: [16110031](//www.ncbi.nlm.nih.gov/pubmed/16110031).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16110031/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  259. Matsumoto K, Shariat SF, Ayala GE, Rauen KA, **Lerner SP**. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology. 2005 Aug; 66(2):441-6. PMID: [16040097](//www.ncbi.nlm.nih.gov/pubmed/16040097).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16040097/citedby/) Fields:

Uro Urology

Translation:Humans

  260. Ziari M, Sonpavde G, Shen S, Teh BS, Shu T, **Lerner SP**. Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 1. Small-cell carcinoma of the urinary bladder. J Clin Oncol. 2005 Jul 01; 23(19):4458-9. PMID: [15994155](//www.ncbi.nlm.nih.gov/pubmed/15994155).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  261. Ziari M, Sonpavde G, Shen S, Zhai J, Teh BS, **Lerner SP**. Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 2. Rhabdomyosarcoma of the urinary bladder in an adult. J Clin Oncol. 2005 Jul 01; 23(19):4459-60. PMID: [15994156](//www.ncbi.nlm.nih.gov/pubmed/15994156).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15994156/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  262. **Lerner SP**. Bladder cancer clinical trials. Urol Oncol. 2005 Jul-Aug; 23(4):275-9. PMID: [16018944](//www.ncbi.nlm.nih.gov/pubmed/16018944).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16018944/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  263. Sule N, Yakupoglu U, Shen SS, [Krishnan B](https://profiles.viictr.org/profile/268034), [Yang G](https://profiles.viictr.org/profile/12582752), **Lerner S** , [Sheikh-Hamad D](https://profiles.viictr.org/profile/266984), [Truong LD](https://profiles.viictr.org/profile/267800). Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005 Apr; 29(4):443-51. PMID: [15767796](//www.ncbi.nlm.nih.gov/pubmed/15767796).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15767796/citedby/) Fields:

Gen General SurgeryPat Pathology

Translation:Humans

  264. Schabath MB, Delclos GL, Grossman HB, Wang Y, **Lerner SP** , Chamberlain RM, [Spitz MR](https://profiles.viictr.org/profile/266382), [Wu X](https://profiles.viictr.org/profile/12582536). Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84. PMID: [15824159](//www.ncbi.nlm.nih.gov/pubmed/15824159).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15824159/citedby/) Fields:

Bio BiochemistryEpi EpidemiologyNeo Neoplasms

Translation:Humans

  265. Shariat SF, Matsumoto K, Casella R, Jian W, **Lerner SP**. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder. Eur Urol. 2005 Jul; 48(1):69-76. PMID: [15967254](//www.ncbi.nlm.nih.gov/pubmed/15967254).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15967254/citedby/) Fields:

Uro Urology

Translation:HumansAnimalsCells

  266. Schabath MB, [Spitz MR](https://profiles.viictr.org/profile/266382), **Lerner SP** , Pillow PC, Hernandez LM, Delclos GL, Grossman HB, [Wu X](https://profiles.viictr.org/profile/12582536). Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51. PMID: [16573375](//www.ncbi.nlm.nih.gov/pubmed/16573375).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16573375/citedby/) Fields:

Neo NeoplasmsNut Nutritional Sciences

Translation:HumansAnimals

  267. Schabath MB, Grossman HB, Delclos GL, Hernandez LM, Day RS, Davis BR, **Lerner SP** , [Spitz MR](https://profiles.viictr.org/profile/266382), [Wu X](https://profiles.viictr.org/profile/12582536). Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9. PMID: [15570038](//www.ncbi.nlm.nih.gov/pubmed/15570038).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15570038/citedby/) Fields:

Nut Nutritional Sciences

Translation:HumansCells

  268. Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, **Lerner SP** , Kim SJ. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res. 2004 Oct 15; 64(20):7355-60. PMID: [15492256](//www.ncbi.nlm.nih.gov/pubmed/15492256).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15492256/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  269. Amiel GE, Shu T, **Lerner SP**. Alternatives to cytology in the management of non-muscle invasive bladder cancer. Curr Treat Options Oncol. 2004 Oct; 5(5):377-89. PMID: [15341676](//www.ncbi.nlm.nih.gov/pubmed/15341676).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  270. Herr H, Lee C, Chang S, **Lerner S** , Bladder Cancer Collaborative Group. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol. 2004 May; 171(5):1823-8; discussion 1827-8. PMID: [15076285](//www.ncbi.nlm.nih.gov/pubmed/15076285).

Citations:
[65](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15076285/citedby/) Fields:

Uro Urology

Translation:Humans

  271. Vazina A, Dugi D, Shariat SF, Evans J, [Link R](https://profiles.viictr.org/profile/266761), **Lerner SP**. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol. 2004 May; 171(5):1830-4. PMID: [15076287](//www.ncbi.nlm.nih.gov/pubmed/15076287).

Citations:
[54](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15076287/citedby/) Fields:

Uro Urology

Translation:Humans

  272. Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, **Lerner SP**. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol. 2004 Mar 15; 22(6):1014-24. PMID: [14981102](//www.ncbi.nlm.nih.gov/pubmed/14981102).

Citations:
[90](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14981102/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  273. Shariat SF, Casella R, Khoddami SM, Hernandez G, Sulser T, Gasser TC, **Lerner SP**. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol. 2004 Feb; 171(2 Pt 1):626-30. PMID: [14713774](//www.ncbi.nlm.nih.gov/pubmed/14713774).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14713774/citedby/) Fields:

Uro Urology

Translation:Humans

  274. Chakraborty A, White SM, **Lerner SP**. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer. Urology. 2004 Jan; 63(1):177-83. PMID: [14751388](//www.ncbi.nlm.nih.gov/pubmed/14751388).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14751388/citedby/) Fields:

Uro Urology

Translation:HumansCells

  275. Shariat SF, Casella R, Monoski MA, Sulser T, Gasser TC, **Lerner SP**. The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer. J Urol. 2003 Dec; 170(6 Pt 1):2244-7. PMID: [14634389](//www.ncbi.nlm.nih.gov/pubmed/14634389).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14634389/citedby/) Fields:

Uro Urology

Translation:Humans

  276. Matsumoto K, Shariat SF, Casella R, [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM, **Lerner SP**. Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy. J Urol. 2003 Dec; 170(6 Pt 1):2248-52. PMID: [14634390](//www.ncbi.nlm.nih.gov/pubmed/14634390).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14634390/citedby/) Fields:

Uro Urology

Translation:Humans

  277. Jiang F, [Caraway NP](https://profiles.viictr.org/profile/12582519), [Sabichi AL](https://profiles.viictr.org/profile/269948), Zhang HZ, Ruitrok A, Grossman HB, [Gu J](https://profiles.viictr.org/profile/12582554), **Lerner SP** , Lippman S, [Katz RL](https://profiles.viictr.org/profile/12582502). Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5. PMID: [12866024](//www.ncbi.nlm.nih.gov/pubmed/12866024).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12866024/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  278. Shariat SF, Matsumoto K, Kim J, Ayala GE, Zhou JH, Jian W, Benedict WF, **Lerner S**. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. J Urol. 2003 Sep; 170(3):985-9. PMID: [12913755](//www.ncbi.nlm.nih.gov/pubmed/12913755).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12913755/citedby/) Fields:

Uro Urology

Translation:Humans

  279. Donoghue AM, Kirby JD, Froman DP, **Lerner SP** , Crouch AN, King LM, Donoghue DJ, Sonstegard TS. Field testing the influence of sperm competition based on sperm mobility in breeder turkey toms. Br Poult Sci. 2003 Jul; 44(3):498-504. PMID: [12964635](//www.ncbi.nlm.nih.gov/pubmed/12964635).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12964635/citedby/) Fields:

Vet Veterinary Medicine

Translation:AnimalsCells

  280. Stadler WM, **Lerner SP**. Perioperative chemotherapy in locally advanced bladder cancer. Lancet. 2003 Jun 07; 361(9373):1922-3. PMID: [12801730](//www.ncbi.nlm.nih.gov/pubmed/12801730).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12801730/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  281. Shariat SF, Kim J, Raptidis G, Ayala GE, **Lerner SP**. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology. 2003 Jun; 61(6):1140-5. PMID: [12809883](//www.ncbi.nlm.nih.gov/pubmed/12809883).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12809883/citedby/) Fields:

Uro Urology

Translation:Humans

  282. Freund CT, Tong XW, [Rowley D](https://profiles.viictr.org/profile/269631), Engehausen D, Frolov A, Kieback DG, **Lerner SP**. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205. PMID: [12810206](//www.ncbi.nlm.nih.gov/pubmed/12810206).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12810206/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCells

  283. Shariat SF, Monoski MA, Andrews B, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP** , Slawin KM. Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urology. 2003 May; 61(5):1053-8. PMID: [12736046](//www.ncbi.nlm.nih.gov/pubmed/12736046).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12736046/citedby/) Fields:

Uro Urology

Translation:Humans

  284. Shariat SF, Kim JH, Ayala GE, Kho K, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol. 2003 Mar; 169(3):938-42. PMID: [12576817](//www.ncbi.nlm.nih.gov/pubmed/12576817).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12576817/citedby/) Fields:

Uro Urology

Translation:Humans

  285. Felknor SA, Delclos GL, **Lerner SP** , Burau KD, Wood SM, Lusk CM, Jalayer AD. Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamine. J Occup Environ Med. 2003 Mar; 45(3):289-94. PMID: [12661186](//www.ncbi.nlm.nih.gov/pubmed/12661186).

Citations:  Fields:

Env Environmental HealthOcc Occupational Medicine

Translation:HumansPHPublic Health

  286. Shariat SF, Kim J, Nguyen C, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP** , Slawin KM. Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. Urology. 2003 Feb; 61(2):359-64. PMID: [12597948](//www.ncbi.nlm.nih.gov/pubmed/12597948).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12597948/citedby/) Fields:

Uro Urology

Translation:Humans

  287. [Zhao H](https://profiles.viictr.org/profile/12582973), Grossman HB, [Spitz MR](https://profiles.viictr.org/profile/266382), **Lerner SP** , Zhang K, [Wu X](https://profiles.viictr.org/profile/12582536). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7. PMID: [12544349](//www.ncbi.nlm.nih.gov/pubmed/12544349).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12544349/citedby/) Fields:

Uro Urology

Translation:Humans

  288. Casella R, Shariat SF, Monoski MA, **Lerner SP**. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma. Cancer. 2002 Dec 15; 95(12):2494-9. PMID: [12467062](//www.ncbi.nlm.nih.gov/pubmed/12467062).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12467062/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  289. Keating MJ, O'Brien S, Kontoyiannis D, Plunkett W, Koller C, Beran M, **Lerner S** , [Kantarjian H](https://profiles.viictr.org/profile/12582901). Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma. 2002 Sep; 43(9):1755-62. PMID: [12685828](//www.ncbi.nlm.nih.gov/pubmed/12685828).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12685828/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  290. Oudat R, Keating MJ, **Lerner S** , O'Brien S, Albitar M. Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission. Leukemia. 2002 Apr; 16(4):632-5. PMID: [11960343](//www.ncbi.nlm.nih.gov/pubmed/11960343).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11960343/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  291. Andrews B, Shariat SF, Kim JH, [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM, **Lerner SP**. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol. 2002 Mar; 167(3):1475-81. PMID: [11832773](//www.ncbi.nlm.nih.gov/pubmed/11832773).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11832773/citedby/) Fields:

Uro Urology

Translation:Humans

  292. Weizer AZ, Shariat SF, Haddad JL, Escudier S, **Lerner SP**. Metastatic transitional cell carcinoma of the urinary bladder to the shoulder girdle. Rev Urol. 2002; 4(2):97-9. PMID: [16985663](//www.ncbi.nlm.nih.gov/pubmed/16985663); PMCID: [PMC1475968](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1475968).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16985663/citedby/)

  293. Shariat SF, Kim JH, Andrews B, Kattan MW, [Wheeler TM](https://profiles.viictr.org/profile/266558), Kim IY, **Lerner SP** , Slawin KM. Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer. 2001 Dec 15; 92(12):2985-92. PMID: [11753975](//www.ncbi.nlm.nih.gov/pubmed/11753975).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11753975/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  294. Belldegrun A, Bander NH, **Lerner SP** , Wood DP, Pantuck AJ. Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer. J Urol. 2001 Oct; 166(4):1316-21. PMID: [11547065](//www.ncbi.nlm.nih.gov/pubmed/11547065).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11547065/citedby/) Fields:

Uro Urology

Translation:HumansCells

  295. Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer. 2001 Sep 15; 92(6):1475-83. PMID: [11745225](//www.ncbi.nlm.nih.gov/pubmed/11745225).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11745225/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  296. Huh YO, Keating MJ, Saffer HL, Jilani I, **Lerner S** , Albitar M. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. Am J Clin Pathol. 2001 Sep; 116(3):437-43. PMID: [11554173](//www.ncbi.nlm.nih.gov/pubmed/11554173).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11554173/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  297. Tokunaga H, Shariat SF, Green AE, Brown RM, Zhou JH, Benedict WF, **Lerner SP**. Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens. Int J Radiat Oncol Biol Phys. 2001 Sep 01; 51(1):16-22. PMID: [11516846](//www.ncbi.nlm.nih.gov/pubmed/11516846).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11516846/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  298. Ibrahim S, Keating M, [Do KA](https://profiles.viictr.org/profile/12582585), O'Brien S, Huh YO, Jilani I, **Lerner S** , [Kantarjian HM](https://profiles.viictr.org/profile/12582901), Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001 Jul 01; 98(1):181-6. PMID: [11418478](//www.ncbi.nlm.nih.gov/pubmed/11418478).

Citations:
[67](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11418478/citedby/) Fields:

Hem Hematology

Translation:Humans

  299. Di Raimondo F, Giustolisi R, **Lerner S** , Cacciola E, O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Keating MJ. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. Ann Oncol. 2001 May; 12(5):621-5. PMID: [11432619](//www.ncbi.nlm.nih.gov/pubmed/11432619).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11432619/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  300. Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. J Urol. 2001 May; 165(5):1473-9. PMID: [11342899](//www.ncbi.nlm.nih.gov/pubmed/11342899).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11342899/citedby/) Fields:

Uro Urology

Translation:Humans

  301. Au JL, Badalament RA, Wientjes MG, Young DC, Warner JA, Venema PL, Pollifrone DL, Harbrecht JD, Chin JL, **Lerner SP** , Miles BJ, International Mitomycin C Consortium. Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst. 2001 Apr 18; 93(8):597-604. PMID: [11309436](//www.ncbi.nlm.nih.gov/pubmed/11309436).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11309436/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  302. O'Brien SM, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Thomas DA, Giles FJ, Freireich EJ, [Cortes J](https://profiles.viictr.org/profile/12582539), **Lerner S** , Keating MJ. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol. 2001 Apr 15; 19(8):2165-70. PMID: [11304768](//www.ncbi.nlm.nih.gov/pubmed/11304768).

Citations:
[120](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11304768/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  303. [Ferrajoli A](https://profiles.viictr.org/profile/12583717), Manshouri T, [Estrov Z](https://profiles.viictr.org/profile/12583285), Keating MJ, O'Brien S, **Lerner S** , Beran M, [Kantarjian HM](https://profiles.viictr.org/profile/12582901), Freireich EJ, Albitar M. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia. Clin Cancer Res. 2001 Apr; 7(4):795-9. PMID: [11309324](//www.ncbi.nlm.nih.gov/pubmed/11309324).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11309324/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  304. Ciancio SJ, Vira M, Simon MA, **Lerner SP** , Schulam PG. Giant bilateral renal angiomyolipomas associated with tuberous sclerosis. Urology. 2001 Mar; 57(3):554. PMID: [11248643](//www.ncbi.nlm.nih.gov/pubmed/11248643).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11248643/citedby/) Fields:

Uro Urology

Translation:Humans

  305. O'Brien SM, [Kantarjian HM](https://profiles.viictr.org/profile/12582901), [Cortes J](https://profiles.viictr.org/profile/12582539), Beran M, Koller CA, Giles FJ, **Lerner S** , Keating M. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol. 2001 Mar 01; 19(5):1414-20. PMID: [11230486](//www.ncbi.nlm.nih.gov/pubmed/11230486).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11230486/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  306. [Link RE](https://profiles.viictr.org/profile/266761), **Lerner SP**. Rebuilding the lower urinary tract after cystectomy: a roadmap for patient selection and counseling. Semin Urol Oncol. 2001 Feb; 19(1):24-36. PMID: [11246731](//www.ncbi.nlm.nih.gov/pubmed/11246731).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11246731/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  307. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, **Lerner S** , Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001 Jan 01; 97(1):256-63. PMID: [11133769](//www.ncbi.nlm.nih.gov/pubmed/11133769).

Citations:
[87](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11133769/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  308. Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology. 2001 Jan; 57(1):60-5. PMID: [11164145](//www.ncbi.nlm.nih.gov/pubmed/11164145).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11164145/citedby/) Fields:

Uro Urology

Translation:Humans

  309. Younes M, Juarez D, Lechago LV, **Lerner SP**. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res. 2001 Jan-Feb; 21(1B):575-8. PMID: [11299807](//www.ncbi.nlm.nih.gov/pubmed/11299807).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11299807/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  310. Shariat SF, Weizer AZ, Green A, [Laucirica R](https://profiles.viictr.org/profile/266515), Frolov A, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Urology. 2000 Nov 01; 56(5):735-40. PMID: [11068290](//www.ncbi.nlm.nih.gov/pubmed/11068290).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11068290/citedby/) Fields:

Uro Urology

Translation:Humans

  311. Schatte EC, **Lerner SP**. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. J Urol. 2000 Nov; 164(5):1670. PMID: [11203071](//www.ncbi.nlm.nih.gov/pubmed/11203071).

Citations:  Fields:

Uro Urology

Translation:Humans

  312. Ghobrial RM, Yersiz H, Farmer DG, Amersi F, Goss J, Chen P, Dawson S, **Lerner S** , Nissen N, Imagawa D, Colquhoun S, Arnout W, McDiarmid SV, Busuttil RW. Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg. 2000 Sep; 232(3):312-23. PMID: [10973381](//www.ncbi.nlm.nih.gov/pubmed/10973381); PMCID: [PMC1421145](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1421145).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10973381/citedby/) Fields:

Gen General Surgery

Translation:Humans

  313. Sutton MA, Freund CT, Berkman SA, Dang TD, Kattan MW, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Rowley DR](https://profiles.viictr.org/profile/269631), **Lerner SP**. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther. 2000 Sep; 2(3):211-7. PMID: [10985951](//www.ncbi.nlm.nih.gov/pubmed/10985951).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10985951/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  314. Freund CT, Tong XW, Block A, Contant CF, Kieback DG, [Rowley DR](https://profiles.viictr.org/profile/269631), **Lerner SP**. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter. Anticancer Res. 2000 Sep-Oct; 20(5A):2811-6. PMID: [11062688](//www.ncbi.nlm.nih.gov/pubmed/11062688).

Citations:  Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  315. [Ravandi-Kashani F](https://profiles.viictr.org/profile/12583711), O'Brien S, Manshouri T, **Lerner S** , Sim S, Dodd K, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Freireich E, Keating M, Albitar M. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia. Leuk Res. 2000 Jun; 24(6):469-74. PMID: [10781679](//www.ncbi.nlm.nih.gov/pubmed/10781679).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10781679/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  316. Freund CT, Sutton MA, Dang T, Contant CF, [Rowley D](https://profiles.viictr.org/profile/269631), **Lerner SP**. Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000 May-Jun; 20(3A):1359-65. PMID: [10928044](//www.ncbi.nlm.nih.gov/pubmed/10928044).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10928044/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  317. Keating MJ, Smith TL, **Lerner S** , O'Brien S, Robertson LE, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Freireich EJ. Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia. Leuk Lymphoma. 2000 Mar; 37(1-2):71-85. PMID: [10721771](//www.ncbi.nlm.nih.gov/pubmed/10721771).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10721771/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  318. Tokunaga H, Lee DH, Kim IY, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Lerner SP**. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res. 1999 Sep; 5(9):2520-5. PMID: [10499628](//www.ncbi.nlm.nih.gov/pubmed/10499628).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10499628/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  319. Mootha RK, Butler R, [Laucirica R](https://profiles.viictr.org/profile/266515), Scardino PT, **Lerner SP**. Renal cell carcinoma with an infrarenal vena caval tumor thrombus. Urology. 1999 Sep; 54(3):561. PMID: [10754141](//www.ncbi.nlm.nih.gov/pubmed/10754141).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10754141/citedby/) Fields:

Uro Urology

Translation:HumansCells

  320. Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, **Lerner SP** , Morton RA. The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients. Yonsei Med J. 1999 Apr; 40(2):118-23. PMID: [10333714](//www.ncbi.nlm.nih.gov/pubmed/10333714).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10333714/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  321. Benedict WF, **Lerner SP** , Zhou J, Shen X, Tokunaga H, [Czerniak B](https://profiles.viictr.org/profile/12582882). Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene. 1999 Feb 04; 18(5):1197-203. PMID: [10022125](//www.ncbi.nlm.nih.gov/pubmed/10022125).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10022125/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  322. Ohori M, Abbas F, [Wheeler TM](https://profiles.viictr.org/profile/266558), Kattan MW, Scardino PT, **Lerner SP**. Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J Urol. 1999 Feb; 161(2):500-4. PMID: [9915435](//www.ncbi.nlm.nih.gov/pubmed/9915435).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9915435/citedby/) Fields:

Uro Urology

Translation:Humans

  323. Adler HL, **Lerner SP**. Renal cell carcinoma and situs inversus viscerum. J Urol. 1998 Dec; 160(6 Pt 1):2141-2. PMID: [9817342](//www.ncbi.nlm.nih.gov/pubmed/9817342).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9817342/citedby/) Fields:

Uro Urology

Translation:Humans

  324. Starostik P, Manshouri T, O'Brien S, Freireich E, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Haidar M, **Lerner S** , Keating M, Albitar M. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res. 1998 Oct 15; 58(20):4552-7. PMID: [9788599](//www.ncbi.nlm.nih.gov/pubmed/9788599).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9788599/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  325. Anaissie EJ, Kontoyiannis DP, O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Robertson L, **Lerner S** , Keating MJ. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med. 1998 Oct 01; 129(7):559-66. PMID: [9758577](//www.ncbi.nlm.nih.gov/pubmed/9758577).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9758577/citedby/) Fields:

Int Internal Medicine

Translation:Humans

  326. [Sabichi AL](https://profiles.viictr.org/profile/269948), **Lerner SP** , Grossman HB, Lippman SM. Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol. 1998 Sep; 10(5):479-84. PMID: [9800121](//www.ncbi.nlm.nih.gov/pubmed/9800121).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9800121/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  327. Keating MJ, O'Brien S, **Lerner S** , Koller C, Beran M, Robertson LE, Freireich EJ, Estey E, [Kantarjian H](https://profiles.viictr.org/profile/12582901). Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood. 1998 Aug 15; 92(4):1165-71. PMID: [9694704](//www.ncbi.nlm.nih.gov/pubmed/9694704).

Citations:
[60](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9694704/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  328. de Lima M, O'Brien S, **Lerner S** , Keating MJ. Chronic lymphocytic leukemia in the young patient. Semin Oncol. 1998 Feb; 25(1):107-16. PMID: [9482532](//www.ncbi.nlm.nih.gov/pubmed/9482532).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9482532/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  329. O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Beran M, Koller C, Talpaz M, **Lerner S** , Keating MJ. Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia. Leukemia. 1997 Oct; 11(10):1631-5. PMID: [9324281](//www.ncbi.nlm.nih.gov/pubmed/9324281).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9324281/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCTClinical Trials

  330. Eastham JA, Kattan MW, Groshen S, Scardino PT, Rogers E, Carlton CE, **Lerner SP**. Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. J Clin Oncol. 1997 Oct; 15(10):3214-22. PMID: [9336358](//www.ncbi.nlm.nih.gov/pubmed/9336358).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9336358/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  331. Cusack JC, Seymour JF, **Lerner S** , Keating MJ, Pollock RE. Role of splenectomy in chronic lymphocytic leukemia. J Am Coll Surg. 1997 Sep; 185(3):237-43. PMID: [9291400](//www.ncbi.nlm.nih.gov/pubmed/9291400).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9291400/citedby/) Fields:

Gen General SurgeryGyn GynecologyObs Obstetrics

Translation:Humans

  332. Herman JR, **Lerner SP**. Current status of gene therapy for prostate and bladder cancer. Int J Urol. 1997 Sep; 4(5):435-40. PMID: [9354942](//www.ncbi.nlm.nih.gov/pubmed/9354942).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9354942/citedby/) Fields:

Uro Urology

Translation:HumansAnimalsCells

  333. [Khouri IF](https://profiles.viictr.org/profile/12582506), Przepiorka D, van Besien K, O'Brien S, Palmer JL, **Lerner S** , Mehra RC, Vriesendorp HM, [Andersson BS](https://profiles.viictr.org/profile/12583670), Giralt S, Keating MJ, [Champlin RE](https://profiles.viictr.org/profile/12582508), K?rbling M. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol. 1997 May; 97(2):466-73. PMID: [9163617](//www.ncbi.nlm.nih.gov/pubmed/9163617).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9163617/citedby/) Fields:

Hem Hematology

Translation:Humans

  334. Baseman AG, Young RR, Young AK, **Lerner SP**. Conservative management of spontaneous rupture of Kock orthotopic ileal reservoir. Urology. 1997 Apr; 49(4):629-31. PMID: [9111641](//www.ncbi.nlm.nih.gov/pubmed/9111641).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9111641/citedby/) Fields:

Uro Urology

Translation:Humans

  335. Sutton MA, Berkman SA, Chen SH, Block A, Dang TD, Kattan MW, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Rowley DR](https://profiles.viictr.org/profile/269631), Woo SL, **Lerner SP**. Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80. PMID: [9037277](//www.ncbi.nlm.nih.gov/pubmed/9037277).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9037277/citedby/) Fields:

Uro Urology

Translation:AnimalsCells

  336. Keating MJ, O'Brien S, McLaughlin P, Dimopoulos M, [Gandhi V](https://profiles.viictr.org/profile/12582526), Plunkett W, **Lerner S** , [Kantarjian H](https://profiles.viictr.org/profile/12582901), Estey E. Clinical experience with fludarabine in hemato-oncology. Hematol Cell Ther. 1996 Dec; 38 Suppl 2:S83-91. PMID: [9137961](//www.ncbi.nlm.nih.gov/pubmed/9137961).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9137961/citedby/) Fields:

Hem Hematology

Translation:Humans

  337. **Lerner SP**. Urinary tract reconstruction--the expanding surgical armamentarium. J Urol. 1996 Dec; 156(6):1929-30. PMID: [8911358](//www.ncbi.nlm.nih.gov/pubmed/8911358).

Citations:  Fields:

Uro Urology

Translation:Humans

  338. Sarosdy MF, [Pisters LL](https://profiles.viictr.org/profile/12582535), Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, **Lerner SP** , Koch MO, Schellhammer PF. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology. 1996 Jul; 48(1):28-32. PMID: [8693647](//www.ncbi.nlm.nih.gov/pubmed/8693647).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8693647/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  339. **Lerner SP**. Testis cancer--progress in risk assessment for occult retroperitoneal lymph node metastases. J Urol. 1996 Feb; 155(2):593-4. PMID: [8558667](//www.ncbi.nlm.nih.gov/pubmed/8558667).

Citations:  Fields:

Uro Urology

Translation:Humans

  340. Bochner BH, **Lerner SP** , Kawachi M, Williams RD, Scardino PT, Skinner DG. Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered? Urology. 1995 Sep; 46(3):408-11. PMID: [7660521](//www.ncbi.nlm.nih.gov/pubmed/7660521).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7660521/citedby/) Fields:

Uro Urology

Translation:Humans

  341. Robertson LE, O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Koller C, Beran M, [Andreeff M](https://profiles.viictr.org/profile/12582880), **Lerner S** , Plunkett W, Keating MJ. A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia. Leukemia. 1995 Sep; 9(9):1444-9. PMID: [7658710](//www.ncbi.nlm.nih.gov/pubmed/7658710).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7658710/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  342. O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Beran M, Robertson LE, Koller C, **Lerner S** , Keating MJ. Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy. Blood. 1995 Aug 15; 86(4):1298-300. PMID: [7632936](//www.ncbi.nlm.nih.gov/pubmed/7632936).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7632936/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  343. **Lerner SP** , Hayani A, O'Hollaren P, Winkel C, Ohori M, Harberg FJ, Roth DR, Gonzales ET. The role of surgery in the management of pediatric pelvic rhabdomyosarcoma. J Urol. 1995 Aug; 154(2 Pt 1):540-5. PMID: [7609132](//www.ncbi.nlm.nih.gov/pubmed/7609132).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7609132/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  344. Robertson LE, O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Koller C, Beran M, [Andreeff M](https://profiles.viictr.org/profile/12582880), **Lerner S** , Keating MJ. Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia. Leukemia. 1995 Jun; 9(6):943-5. PMID: [7596181](//www.ncbi.nlm.nih.gov/pubmed/7596181).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7596181/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCTClinical Trials

  345. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, **Lerner SP** , Yang AS, Cote R, Schm?tte C, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. 1994 Feb 01; 54(3):784-8. PMID: [8306342](//www.ncbi.nlm.nih.gov/pubmed/8306342).

Citations:
[89](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8306342/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  346. O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Beran M, Smith T, Koller C, Estey E, Robertson LE, **Lerner S** , Keating M. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood. 1993 Sep 15; 82(6):1695-700. PMID: [8400226](//www.ncbi.nlm.nih.gov/pubmed/8400226).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8400226/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  347. Miyao N, Tsai YC, **Lerner SP** , Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Role of chromosome 9 in human bladder cancer. Cancer Res. 1993 Sep 01; 53(17):4066-70. PMID: [8358736](//www.ncbi.nlm.nih.gov/pubmed/8358736).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8358736/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  348. Kemena A, O'Brien S, [Kantarjian H](https://profiles.viictr.org/profile/12582901), Robertson L, Koller C, Beran M, Estey E, Plunkett W, **Lerner S** , Keating MJ. Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule. Leuk Lymphoma. 1993 Jun; 10(3):187-93. PMID: [8220117](//www.ncbi.nlm.nih.gov/pubmed/8220117).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8220117/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCTClinical Trials

  349. **Lerner SP** , Skinner DG, Lieskovsky G, Boyd SD, Groshen SL, Ziogas A, Skinner E, Nichols P, Hopwood B. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol. 1993 Apr; 149(4):758-64; discussion 764-5. PMID: [8455238](//www.ncbi.nlm.nih.gov/pubmed/8455238).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8455238/citedby/) Fields:

Uro Urology

Translation:Humans

  350. Keating MJ, Holmes R, **Lerner S** , Ho DH. L-asparaginase and PEG asparaginase--past, present, and future. Leuk Lymphoma. 1993; 10 Suppl:153-7. PMID: [8481665](//www.ncbi.nlm.nih.gov/pubmed/8481665).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8481665/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimals

  351. **Lerner SP** , Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol Clin North Am. 1992 Nov; 19(4):713-23. PMID: [1279876](//www.ncbi.nlm.nih.gov/pubmed/1279876).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1279876/citedby/) Fields:

Uro Urology

Translation:Humans

  352. Meredith S, Dudenhoeffer G, Butcher RL, **Lerner SP** , Walls T. Unilateral ovariectomy increases loss of primordial follicles and is associated with increased metestrous concentration of follicle-stimulating hormone in old rats. Biol Reprod. 1992 Aug; 47(2):162-8. PMID: [1391322](//www.ncbi.nlm.nih.gov/pubmed/1391322).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1391322/citedby/) Fields:

Rep Reproductive Medicine

Translation:Animals

  353. **Lerner SP** , Seale-Hawkins C, Carlton CE, Scardino PT. The risk of dying of prostate cancer in patients with clinically localized disease. J Urol. 1991 Oct; 146(4):1040-5. PMID: [1895420](//www.ncbi.nlm.nih.gov/pubmed/1895420).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1895420/citedby/) Fields:

Uro Urology

Translation:Humans

  354. Gleeson M, **Lerner SP** , Griffith DP. Treatment of staghorn calculi with extracorporeal shock-wave lithotripsy and percutaneous nephrolithotomy. Urology. 1991 Aug; 38(2):145-51. PMID: [1877132](//www.ncbi.nlm.nih.gov/pubmed/1877132).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1877132/citedby/) Fields:

Uro Urology

Translation:Humans

  355. Shabsigh R, **Lerner S** , Fishman IJ, [Kadmon D](https://profiles.viictr.org/profile/268024). The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. J Urol. 1989 May; 141(5):1206-9. PMID: [2651723](//www.ncbi.nlm.nih.gov/pubmed/2651723).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2651723/citedby/) Fields:

Uro Urology

Translation:Humans

  356. **Lerner SP** , Gleeson MJ, Griffith DP. Infection stones. J Urol. 1989 Mar; 141(3 Pt 2):753-8. PMID: [2645435](//www.ncbi.nlm.nih.gov/pubmed/2645435).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2645435/citedby/) Fields:

Uro Urology

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 345 publications over 31 distinct years, with a maximum of
19 publications in 2006 and
2010](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|19&cht=bvs&chd=t:5,26,21,37,32,26,42,89,26,68,42,58,100,63,89,74,100,53,74,37,95,79,89,84,53,68,47,63,42,74,58&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 1  
1995| 5  
1996| 4  
1997| 7  
1998| 6  
1999| 5  
2000| 8  
2001| 17  
2002| 5  
2003| 13  
2004| 8  
2005| 11  
2006| 19  
2007| 12  
2008| 17  
2009| 14  
2010| 19  
2011| 10  
2012| 14  
2013| 7  
2014| 18  
2015| 15  
2016| 17  
2017| 16  
2018| 10  
2019| 13  
2020| 9  
2021| 12  
2022| 8  
2023| 14  
2024| 11  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

LERNER's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (768)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Urinary Bladder Neoplasms](https://profiles.viictr.org/profile/251465)
  * [Carcinoma, Transitional Cell](https://profiles.viictr.org/profile/257285)
  * [Cystectomy](https://profiles.viictr.org/profile/240344)
  * [Cystoscopy](https://profiles.viictr.org/profile/252788)
  * [Neoplasm Invasiveness](https://profiles.viictr.org/profile/264249)

[Explore](https://profiles.viictr.org/profile/267959/198)

_

Co-Authors (86)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [KAMAT, ASHISH](https://profiles.viictr.org/profile/12582620)
  * [MATIN, SURENA](https://profiles.viictr.org/profile/12583401)
  * [DINNEY, COLIN P](https://profiles.viictr.org/profile/12583684)
  * [GODOY, GUILHERME](https://profiles.viictr.org/profile/267612)
  * [PUTLURI, NAGIREDDY](https://profiles.viictr.org/profile/269361)

[Explore](https://profiles.viictr.org/profile/267959/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KAMAT, ASHISH](https://profiles.viictr.org/profile/12582620)
  * [DINNEY, COLIN P](https://profiles.viictr.org/profile/12583684)
  * [SIEFKER-RADTKE, ARLENE ODELIA](https://profiles.viictr.org/profile/12582595)
  * [MATIN, SURENA](https://profiles.viictr.org/profile/12583401)
  * [GUO, CHARLES CHUANHAI](https://profiles.viictr.org/profile/12583087)

[Explore](https://profiles.viictr.org/profile/267959/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [BABAIAN, KARA](https://profiles.viictr.org/profile/41415757)
  * [COBURN, MICHAEL](https://profiles.viictr.org/profile/266826)
  * [GOLDFARB, RICHARD](https://profiles.viictr.org/profile/267391)
  * [KAAKI, BASIL](https://profiles.viictr.org/profile/6618429)
  * [SWEENEY, DANIELLE](https://profiles.viictr.org/profile/41694579)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [COBURN, MICHAEL](https://profiles.viictr.org/profile/266826)
  * [JORGEZ, CAROLINA](https://profiles.viictr.org/profile/266145)
  * [KHERA, MOHIT](https://profiles.viictr.org/profile/266483)
  * [LINK, RICHARD](https://profiles.viictr.org/profile/266761)
  * [SMITH, CHRISTOPHER](https://profiles.viictr.org/profile/266749)

_

